Cardiomyopathy (excluding other)

FG_CARDMYO

cardiomyopathy: A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints I9_CARDMPRI I9_CARDMSEC I9_CARDMYOHYP	5490
6. Filter based on genotype QC (FinnGen only)	5490

Control definitions (FinnGen only)

Control exclude: FG_OTHHEART

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF2

NAME	FG_CARDMYO
CONTROL_EXCLUDE	FG_OTHHEART
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	I9_CARDMPRI\|I9_CARDMSEC\|I9_CARDMYOHYP
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cardiomyopathy (excluding other) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	44956	11872	32437
Only index persons	32361	8972	23389
Unadjusted period prevalence (%)
Whole population	0.75	0.34	0.91
Only index persons	0.74	0.33	0.89
Median age at first event (years)
Whole population	61.62	64.77	60.42
Only index persons	61.62	64.02	60.70

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5490	1492	3998
Unadjusted period prevalence (%)	1.42	0.51	1.76
Median age at first event (years)	61.56	60.97	61.78

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4982: Matched controls
49818

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I42.0

ICD-10 Finland

Dilated cardiomyopathy

4503599627370496.0

323.0

4278

GD1LA

NOMESCO Finland

114.0

323.0

360

I50.1

ICD-10 Finland

Left ventricular failure

7819.5

323.0

1641

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

16.1

323.0

2513

2956

C03DA01

ATC

spironolactone; oral

35.1

323.0

2588

1486

B01AF02

ATC

apixaban; oral

17.9

323.0

720

465

TFP20

NOMESCO Finland

Cardiodefibrillation

320.5

323.0

959

XF404

NOMESCO Finland

Ambulatory ECG

12.8

323.0

1153

1144

C01AA05

ATC

digoxin; systemic

65.9

323.0

1454

309

C07AB07

ATC

bisoprolol; oral

12.4

323.0

4056

12970

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

145.7

323.0

451

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

75.8

323.0

386

C01BD01

ATC

amiodarone; systemic

457.9

323.0

781

AN1

Coronary angiography

8.9

323.0

1653

2635

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

709.6

323.0

1278

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

160.0

323.0

425

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

323.0

478

K78

ICPC

Atrial fibrillation/flutter

33.1

323.0

716

251

201

Kela drug reimbursment

Chronic cardiac insufficiency

187.3

323.0

2540

275

I50.0

ICD-10 Finland

Congestive heart failure

808.6

323.0

1568

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

192.6

323.0

391

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

108.8

323.0

437

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

140.1

323.0

376

I50.9

ICD-10 Finland

Heart failure, unspecified

393.0

323.0

2830

166

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

149.9

323.0

997

C03CA01

ATC

furosemide; systemic

19.6

323.0

3605

5856

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

323.0

1099

C09DX04

ATC

valsartan and sacubitril; oral

+∞

323.0

550

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

323.0

607

207

Kela drug reimbursment

Chronic arrhythmias

351.1

323.0

1770

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

11.9

323.0

2404

3624

I47.2

ICD-10 Finland

Ventricular tachycardia

1083.9

323.0

660

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

+∞

323.0

326

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

11.0

323.0

692

718

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

11.9

323.0

2912

5259

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.7

323.0

2916

13718

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

114.2

323.0

438

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

168.8

323.0

1653

146

I50

ICD-10 Finland

Heart failure

55.0

323.0

465

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

524.7

323.0

1270

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

+∞

323.0

588

B01AA03

ATC

warfarin; systemic

20.3

323.0

2479

2320

I44.2

ICD-10 Finland

Atrioventricular block, complete

3332.7

323.0

323

C09AA05

ATC

ramipril; oral

7.0

323.0

2693

7147

I48

ICD-10 Finland

Atrial fibrillation and flutter

199.3

323.0

2478

246

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

225.1

323.0

451

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

10.3

323.0

1007

1200

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

165.6

323.0

1318

108

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.3

323.0

1386

3382

R06.0

ICD-10 Finland

Dyspnoea

3.8

320.4

1691

5873

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

1678.6

318.8

307

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

3084.5

314.6

301

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

+∞

313.8

298

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

1069.4

311.6

302

I25.1

ICD-10 Finland

Atherosclerotic heart disease

3.7

308.0

1745

6389

TFP34

NOMESCO Finland

Electrophysiological investigation

188.9

290.9

302

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1388.3

272.1

263

XF400

NOMESCO Finland

ECG with 12 standard connections

3.9

268.6

1309

4140

K77

ICPC

Heart failure

60.8

266.8

314

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

178.9

259.9

271

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

37.4

252.3

326

M04AA01

ATC

allopurinol; systemic

4.0

250.8

1165

3504

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

+∞

247.9

236

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

328.9

246.4

248

I35.0

ICD-10 Finland

Aortic (valve) stenosis

41.4

237.4

300

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

+∞

237.3

226

I48.1

ICD-10 Finland

Persistent atrial fibrillation

314.4

235.9

238

I47.1

ICD-10 Finland

Supraventricular tachycardia

56.3

232.4

277

Angiography of the heart and coronary arteries

5.9

229.5

699

1338

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

7.1

227.3

596

933

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

224.6

214

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

219.3

209

C07AA07

ATC

sotalol; systemic

13.2

215.4

392

320

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

210.0

214.2

221

WX892

NOMESCO Finland

Monitored bed care

5.5

210.8

680

1387

XF640

NOMESCO Finland

15.8

209.9

353

239

1CX08

NOMESCO Finland

431.1

208.9

208

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

65.1

197.5

230

I42.8

ICD-10 Finland

Other cardiomyopathies

260.2

196.3

200

I42

ICD-10 Finland

Cardiomyopathy

+∞

188.7

180

4254A

ICD-9 Finland

Cardiomyopathy, Other primary cardiomyopathies

+∞

184.5

176

I49.5

ICD-10 Finland

Sick sinus syndrome

16.6

179.7

296

189

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

9.4

177.5

385

441

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

122.7

175.4

189

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

359.4

174.4

175

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

5.5

166.8

533

1062

C07AG02

ATC

carvedilol; oral

4.8

162.5

593

1368

A12BA01

ATC

potassium chloride; oral

7.1

162.3

420

635

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

66.9

161.3

187

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

21.4

160.5

241

118

AP1

Catheterization of the left side of the heart

16.3

156.4

259

167

I34.1

ICD-10 Finland

Mitral (valve) prolapse

83.0

156.4

176

C07AB02

ATC

metoprolol; systemic

2.7

152.6

1256

5480

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.6

152.1

1461

6964

Z94.1

ICD-10 Finland

Heart transplant status

121.0

152.0

164

XFE00

NOMESCO Finland

Epicardial ultrasonography

11.8

152.0

290

259

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

17.5

151.1

243

145

TFJ02

NOMESCO Finland

Muscle biopsy of heart

495.2

146.2

145

WX872

NOMESCO Finland

Intensive care

6.0

145.6

429

770

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

145.5

139

M10.9

ICD-10 Finland

Gout, unspecified

4.4

144.5

576

1444

C01BC04

ATC

flecainide; systemic

46.0

144.2

178

XF402

NOMESCO Finland

ECG with work load test

3.5

144.0

774

2516

TPH07

NOMESCO Finland

Cathetrisation of artery

3.5

143.0

748

2379

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

13.7

142.7

254

195

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

7.2

141.8

361

531

K84

ICPC

Heart disease other

9.9

139.0

291

311

I44.1

ICD-10 Finland

Atrioventricular block, second degree

208.6

137.5

142

I42.6

ICD-10 Finland

Alcoholic cardiomyopathy

+∞

135.0

129

ZX120

NOMESCO Finland

Intravenous

3.6

134.3

672

2056

TPH04

NOMESCO Finland

Cathetrisation of vein

2.6

133.7

1204

5473

I49.3

ICD-10 Finland

Ventricular premature depolarization

4.6

130.8

489

1146

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.4

128.2

1369

6792

ASB

Insertion of a biventricular physiological pacemaker DDD (R)

+∞

127.6

122

AS7

Arrhythmia pacemaker insertion VVI (R) S

+∞

126.6

121

TFP35

NOMESCO Finland

Electroanatomical mapping

107.5

124.6

136

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

417.5

123.3

123

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.7

122.6

974

4090

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

+∞

122.4

117

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.3

119.5

1417

7361

I25.2

ICD-10 Finland

Old myocardial infarction

3.9

117.1

521

1434

AQ1

Conventional electrophysiological examination

153.6

113.7

120

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.7

113.5

902

3772

AP4

Myocardial biopsy

293.2

112.5

114

B01AB05

ATC

enoxaparin; parenteral

2.2

112.1

1570

8753

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

+∞

110.8

106

250

Kela drug reimbursment

+∞

110.8

106

R4110

NOMESCO Finland

Physiotherapy

2.2

110.7

1439

7748

FPG40

NOMESCO Finland

Replacement of pulse generator in transvenous cardioverter-defibrillator

+∞

109.8

105

Electrophysiological Special Examination

285.0

109.4

111

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

70.5

108.0

124

I42.5

ICD-10 Finland

Other restrictive cardiomyopathy

+∞

105.6

101

H02AB06

ATC

prednisolone; systemic

1.9

104.4

2296

15227

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

+∞

103.5

R02

ICPC

Shortness of breath/dyspnoea

3.1

103.4

647

2312

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.3

102.5

1132

5614

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.5

101.6

317

605

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.7

99.2

471

1364

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

976.9

98.4

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.0

97.8

629

2284

C01DA14

ATC

isosorbide mononitrate; oral

2.5

97.4

891

3996

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

+∞

97.2

C09AA02

ATC

enalapril; systemic

2.2

96.9

1207

6309

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

57.7

95.5

113

B01AE07

ATC

dabigatran etexilate; oral

8.3

94.9

218

272

A46

ICD-10 Finland

Erysipelas

2.5

93.3

812

3539

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

241.9

92.8

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

+∞

91.9

XF409

NOMESCO Finland

Other special ECG

46.2

91.9

113

AS4

Physiological pacemaker insertion DDD (R)

51.0

91.1

110

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.4

89.9

479

1516

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

6.5

89.3

243

389

127

Kela drug reimbursment

Transplant complication

9.7

89.0

187

200

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.9

88.7

611

2312

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

88.7

744

3169

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.8

88.7

412

1168

WX740

NOMESCO Finland

Nitrogen oxide therapy

187.3

88.5

B01AF01

ATC

rivaroxaban; oral

3.0

88.1

562

2022

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

3.2

87.9

520

1776

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

44.1

87.0

108

A10BK01

ATC

dapagliflozin; oral

4.1

86.5

366

955

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

+∞

85.6

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

60.0

85.1

100

TK800

NOMESCO Finland

Hemodialysis

7.4

84.2

209

294

AS6

Biventricular physiological heart failure pacemaker insertion DDD (R)

+∞

83.5

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

83.5

1403

8224

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.1

83.0

513

1801

FPE25

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, atrial and ventricular electrodes, CRT-P (DDDR)

+∞

80.4

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.8

78.0

355

986

L04AA06

ATC

mycophenolic acid; systemic

8.4

77.1

175

214

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

76.8

1479

9062

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

+∞

76.2

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.1

75.6

1095

6013

K83

ICPC

Heart valve disease NOS

63.2

74.7

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

5.2

73.5

238

472

C10AA01

ATC

simvastatin; oral

1.7

73.2

2320

16662

C09AA04

ATC

perindopril; oral

3.4

73.0

377

1160

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

367.5

72.8

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

250.2

72.5

Initial pacemaker installation

130.2

72.1

K99

ICPC

Cardiovascular disease other

7.0

71.4

184

273

I45.9

ICD-10 Finland

Conduction disorder, unspecified

74.9

71.3

AP2

Catheterization of the right side of the heart

68.5

70.5

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

70.4

837

4206

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

4.4

69.3

267

636

FPE36

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with ventricular electrodes

+∞

68.9

A10BA02

ATC

metformin; oral

1.8

68.0

1488

9446

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

+∞

67.8

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.6

67.5

532

2164

N18.8

ICD-10 Finland

Other chronic renal failure

5.3

66.8

212

411

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.4

66.4

646

2944

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

+∞

65.7

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

24.9

65.5

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

13.3

64.7

115

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

+∞

64.7

C08DA01

ATC

verapamil; systemic

4.6

64.2

233

523

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.9

63.8

411

1476

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

+∞

63.7

7AX01

NOMESCO Finland

+∞

63.7

R00.1

ICD-10 Finland

Bradycardia, unspecified

5.4

63.4

198

377

AP3

Catheterization of the right and left side of the heart

219.3

63.3

R03BB04

ATC

tiotropium bromide; inhalant

2.4

62.1

593

2671

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.4

62.1

585

2617

Catheterization and pressure measurement of the right side of the heart

56.9

61.8

C10AA05

ATC

atorvastatin; oral

1.7

61.6

1943

13698

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

3.1

61.4

355

1184

R55

ICD-10 Finland

Syncope and collapse

2.4

61.2

584

2629

FM1DM

NOMESCO Finland

Heart very extensive MRI examination with 3 Tesla magnet

605.1

60.9

4251A

ICD-9 Finland

Cardiomyopathy, Hypertrophic obstructive cardiomyopathy

+∞

60.5

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

3.9

60.5

264

705

R03AC02

ATC

salbutamol; inhalant

1.7

60.1

2197

16102

AA1AD

NOMESCO Finland

CT of head and brain

1.9

59.7

1134

6805

3A064

NOMESCO Finland

59.1

59.6

Z50.0

ICD-10 Finland

Cardiac rehabilitation

9.5

59.5

125

134

M10.0

ICD-10 Finland

Idiopathic gout

4.2

59.5

236

578

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

+∞

59.5

ATX

Other pacemaker replacement or related action, such as cord removal or replacement

127.5

58.9

Catheter ablation of arrhythmia

584.6

58.8

FPJ00

NOMESCO Finland

Revision of pacemaker pulse generator or electrode

300.5

58.4

3AC01

NOMESCO Finland

11.6

58.0

110

FPJ22

NOMESCO Finland

Revision of cardioverter-defibrillator with atrial and ventricular electrodes

574.4

57.7

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

+∞

57.4

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.6

57.0

464

1916

AS2

Ventricular pacemaker insertion VVI (R)

151.7

57.0

C01BA03

ATC

disopyramide; systemic

36.5

56.0

TK810

NOMESCO Finland

Hemofiltration

16.9

56.0

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

55.7

783

4184

M10

ICD-10 Finland

Gout

3.2

55.5

310

1008

FPJ21

NOMESCO Finland

Revision of cardioverter-defibrillator with ventricular electrode

+∞

55.3

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

55.2

1232

7767

E87.5

ICD-10 Finland

Hyperkalaemia

7.5

54.8

133

181

D64.9

ICD-10 Finland

Anaemia, unspecified

2.3

54.4

536

2446

N19

ICD-10 Finland

Unspecified kidney failure

4.1

54.3

220

549

4259X

ICD-9 Finland

Cardiomyopathy, Secondary cardiomyopathy, unspecified

188.6

54.0

XF600

NOMESCO Finland

Bloodpressure measurement

2.9

53.3

348

1257

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

52.8

858

4842

WX722

NOMESCO Finland

PEEP

3.2

52.7

300

988

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

21.4

52.7

A10BH05

ATC

linagliptin; oral

3.2

52.4

296

967

4289X

ICD-9 Finland

Heart failure, unspecified

+∞

52.2

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.3

52.1

164

315

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

5.4

51.8

162

309

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

32.8

51.7

I46.9

ICD-10 Finland

Cardiac arrest, unspecified

+∞

51.1

R04.0

ICD-10 Finland

Epistaxis

2.7

51.0

378

1477

Initial installation of the atrial pacemaker

136.4

50.9

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

6.8

50.7

131

196

E66.00

ICD-10 Finland

Metabolic syndrome

3.2

50.4

287

945

FL1AC

NOMESCO Finland

Left cardioangiography

6.6

50.2

133

206

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.5

50.1

441

1894

ARB

Catheter ablation of arrhythmia: Cutiing or modification of the AV node

+∞

50.1

FPE24

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, ventricular electrodes, CRT-P (VVIR)

+∞

50.1

C01BA01

ATC

quinidine; oral

41.8

49.8

J01FF01

ATC

clindamycin; systemic

1.7

49.7

1228

7945

M01AE01

ATC

ibuprofen; systemic, rectal

0.6

49.6

3190

36908

TKC20

NOMESCO Finland

Catheterisation of bladder

2.5

49.5

418

1758

T90

ICPC

Diabetes non-insulin dependent

1.7

49.0

1174

7518

ZX108

NOMESCO Finland

Inhalation

11.0

49.0

C09AA01

ATC

captopril; oral

5.2

48.9

157

309

B01AF03

ATC

edoxaban; oral

20.8

48.3

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

27.8

48.2

S97

ICPC

Chronic ulcer skin

3.0

47.0

293

1026

Cardiac muscle biopsy

+∞

46.9

FPJ23

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with ventricular electrodes

+∞

46.9

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.3

46.8

147

282

WX902

NOMESCO Finland

External defibrillation of heart

126.2

46.8

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.1

46.5

274

924

742

NOMESCO Finland

75.1

46.0

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.3

46.0

460

2107

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

45.9

1211

7955

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

+∞

44.8

A10BK03

ATC

empagliflozin; oral

2.4

44.6

398

1719

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

25.1

44.1

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

+∞

43.8

A11CC03

ATC

alfacalcidol; systemic

4.8

43.6

150

319

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.0

43.6

266

917

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.7

43.5

199

554

I44.0

ICD-10 Finland

Atrioventricular block, first degree

12.3

43.2

Catheterization and pressure measurement of the left side of the heart

5.2

43.1

138

271

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

116.0

42.8

FQA00

NOMESCO Finland

Orthotopic transplantation of heart

+∞

41.7

J01DB01

ATC

cefalexin; oral

1.6

41.7

3625

31471

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.2

41.6

134

265

FPG42

NOMESCO Finland

Replacement of electrode(s) in transvenous cardioverter-defibrillator

+∞

40.7

A10AE04

ATC

insulin glargine; parenteral

2.2

40.4

469

2295

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

27.8

40.3

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

40.2

1203

8133

I47.0

ICD-10 Finland

Re-entry ventricular arrhythmia

400.5

40.1

FPJ

NOMESCO Finland

Review and replacement of pacemaker or internal defibrillator device or electrode

206.5

39.9

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.4

39.8

205

627

A02BC02

ATC

pantoprazole; systemic

1.5

39.7

2807

23131

C09CA03

ATC

valsartan; oral

2.2

39.4

457

2233

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

16.8

39.3

E66.01

ICD-10 Finland

Obesity due to excess calories

2.6

39.1

300

1193

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.8

39.1

271

1015

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

390.3

39.1

C03AA03

ATC

hydrochlorothiazide; oral

2.1

39.0

464

2293

AQ2

Electrophysiological electroanatomical examination

201.4

38.9

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.8

38.5

261

964

J01MA12

ATC

levofloxacin; systemic

1.7

38.2

884

5550

J01CA04

ATC

amoxicillin; systemic

1.5

38.0

3418

29499

G47.3

ICD-10 Finland

Sleep apnoea

1.7

38.0

998

6495

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.7

37.9

274

1051

WX002

NOMESCO Finland

Sedation and analgesia

1.7

37.5

887

5596

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

12.8

37.4

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.5

37.3

312

1301

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

5.3

37.0

117

227

K29

ICPC

Cardiovascular sympt/complt other

3.0

37.0

220

746

WX882

NOMESCO Finland

High dependency care

3.7

37.0

167

460

I20.00

ICD-10 Finland

Unstable angina

3.5

37.0

183

543

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.1

36.9

479

2455

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.4

36.7

338

1480

ASA

Insertion of a biventricular pacemaker VVI (R) S

+∞

36.5

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

+∞

36.5

I20.09

ICD-10 Finland

Unstable angina

2.5

36.5

294

1202

C02EA02

ATC

2.7

36.3

269

1049

E05.89

ICD-10 Finland

Other thyrotoxicosis

27.5

35.9

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

186.2

35.8

T92

ICPC

Gout

4.3

35.4

137

329

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.2

35.2

193

619

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.2

35.2

194

625

A41.9

ICD-10 Finland

Sepsis, unspecified

3.2

35.0

196

638

K80

ICPC

Cardiac arrhythmia NOS

2.6

34.8

262

1030

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

181.2

34.8

M01AH05

ATC

etoricoxib; oral

0.7

34.7

1622

20675

XFP02

NOMESCO Finland

124.2

34.7

AS5

Biventricular heart failure pacemaker insertion VVI (R)

+∞

34.4

WX730

NOMESCO Finland

Conventional respirator

5.2

34.2

108

210

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.4

33.9

174

532

N02BE01

ATC

paracetamol; systemic, rectal

1.5

33.8

3807

33942

FXE00

NOMESCO Finland

Use of ECLA

176.1

33.7

TFC20

NOMESCO Finland

Catheterisation of both sides of heart

176.1

33.7

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

93.2

33.7

J01MA14

ATC

moxifloxacin; systemic

2.1

33.6

409

2036

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

+∞

33.4

342

Kela drug reimbursment

Dronedarone

+∞

33.4

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.5

33.0

280

1173

E66.8

ICD-10 Finland

Other obesity

3.0

33.0

203

705

R2110

NOMESCO Finland

Giving the first information

2.5

33.0

262

1062

C08DB01

ATC

diltiazem; oral

2.6

32.9

255

1019

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

329.1

32.9

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

32.6

821

5256

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

32.5

1462

10796

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.6

32.4

251

1003

I41.8

ICD-10 Finland

Myocarditis in other diseases classified elsewhere

+∞

32.3

H03BB01

ATC

carbimazole; oral

3.4

32.3

162

487

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.9

32.2

199

694

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

6.6

32.1

129

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.1

32.1

377

1850

A10BH01

ATC

sitagliptin; oral

1.9

32.0

475

2557

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.1

32.0

179

583

FM1CD

NOMESCO Finland

Very extensive CT of heart

72.6

31.9

WX930

NOMESCO Finland

Thepapeutic hypothermia

166.0

31.7

XF622

NOMESCO Finland

Measurement of minute volume of heart

22.1

31.7

I48.3

ICD-10 Finland

Typical atrial flutter

114.0

31.7

R50.9

ICD-10 Finland

Fever, unspecified

1.8

31.6

592

3459

R04.2

ICD-10 Finland

Haemoptysis

3.0

31.5

193

669

G04BE03

ATC

sildenafil; oral

3.7

31.4

141

387

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

27.1

31.4

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

31.4

1221

8713

N17.8

ICD-10 Finland

Other acute renal failure

7.1

31.3

112

I42.4

ICD-10 Finland

Endocardial fibroelastosis

+∞

31.3

AK1

HTX (heart transplant)

+∞

31.3

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.9

31.1

483

2644

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

31.0

302

1360

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.0

31.0

128

327

N05CF01

ATC

zopiclone; oral

1.5

30.7

1377

10134

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.3

30.5

116

275

FPG04

NOMESCO Finland

Insertion of internal defibrillator, atrial and chamber electrode

+∞

30.2

4271A

ICD-9 Finland

Cardiac dysrhythmias, Paroxysmal ventricular tachycardia

+∞

30.2

42700

ICD-8 Finland

Symptomatic heart disease, Congestive heart failure

+∞

30.2

R53

ICD-10 Finland

Malaise and fatigue

1.7

30.2

756

4822

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.8

30.2

200

729

H02AB07

ATC

prednisone; oral

1.8

30.1

616

3700

A10BB12

ATC

glimepiride; oral

2.1

30.1

375

1883

SPAT1263

SPAT

Sampling

1.5

30.1

1680

12928

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.2

29.9

338

1629

K60

ICPC

Cardiovascular, Result test/procedure

11.1

29.9

205

Kela drug reimbursment

Chronic hypertension

1.5

29.7

1329

9767

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

29.6

593

3535

TFP40

NOMESCO Finland

Ablation treatment for a-v node re-entry activation

+∞

29.2

I42.3

ICD-10 Finland

Endomyocardial (eosinophilic) disease

+∞

29.2

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

29.0

583

3479

I48.4

ICD-10 Finland

Atypical atrial flutter

293.5

28.8

AR5

Catheter ablation of arrhythmia, target: atrial flutter

293.5

28.8

FPJ04

NOMESCO Finland

Revision of pacemaker generator with atrial and ventricular electrodes

80.6

28.7

GD1AD

NOMESCO Finland

Thorax CT examination

2.6

28.7

221

880

Z71.8

ICD-10 Finland

Other specified counselling

1.6

28.6

867

5809

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.1

28.5

339

1668

C07AB03

ATC

atenolol; systemic

2.2

28.3

291

1343

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

28.2

603

3667

SPAT1255

SPAT

Intravenous administration of medicine

2.2

28.1

299

1403

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.5

28.0

230

948

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

4.1

27.9

110

270

5AB14

NOMESCO Finland

24.5

27.8

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

9.6

27.8

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

27.8

2626

22150

C01BB02

ATC

mexiletine; systemic

32.9

27.7

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.2

27.7

150

478

TFC99

NOMESCO Finland

Catheterisation of heart with other procedure

100.6

27.7

FK1BT

NOMESCO Finland

Implantation of cardiac pacemaker with X-ray guidance

145.7

27.6

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.7

27.5

194

735

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.9

27.4

169

589

C02EA01

ATC

4.9

27.3

185

AA1

Conventional CABG

3.8

27.2

119

321

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

2.5

27.1

229

960

FPH00

NOMESCO Finland

Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator

+∞

27.1

AB2

AVR bio, stent

+∞

27.1

C01BD07

ATC

dronedarone; oral

+∞

27.1

212

Kela drug reimbursment

Gout

3.4

27.0

132

390

S18

ICPC

Laceration/cut

1.4

26.9

1808

14326

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

3.3

26.8

141

440

I45.3

ICD-10 Finland

Trifascicular block

272.4

26.7

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

26.7

457

2586

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

140.7

26.6

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

26.6

1864

14873

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.0

26.5

338

1713

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.9

26.5

113

298

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.9

26.3

179

B01AC04

ATC

clopidogrel; oral

1.6

26.3

729

4764

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.3

26.2

155

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

+∞

26.1

42500

ICD-8 Finland

Cardiomyopathy, Stenosis subaortae hypertrophicans

+∞

26.1

FXM00

NOMESCO Finland

Removal of extra-, para- or intracorporeal VAD

+∞

26.1

C09CA01

ATC

losartan; oral

1.5

25.9

1023

7278

I45.2

ICD-10 Finland

Bifascicular block

31.1

25.9

I44.6

ICD-10 Finland

Other and unspecified fascicular block

73.0

25.8

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.5

25.7

209

858

XF406

NOMESCO Finland

High resolution ECG

93.8

25.6

J81

ICD-10 Finland

Pulmonary oedema

11.8

25.6

N02AX02

ATC

tramadol; systemic, rectal

1.4

25.4

1848

14808

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.4

25.3

124

367

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.3

25.1

240

1071

I44.3

ICD-10 Finland

Other and unspecified atrioventricular block

+∞

25.0

FKC96

NOMESCO Finland

Other repair of mitral valve for insufficiency

+∞

25.0

FPJ12

NOMESCO Finland

Revision of biventricular CRT-P (DDDR) generator

+∞

25.0

N18.0

ICD-10 Finland

End-stage renal disease

5.9

24.8

120

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

24.8

1547

12048

42509

ICD-8 Finland

Cardiomyopathy, Unspecified

70.2

24.8

L28

ICPC

Limited function/disability (L)

1.7

24.8

617

3915

J96.1

ICD-10 Finland

Chronic respiratory failure

3.8

24.7

106

282

AB1

AVR mechanical

251.3

24.7

I95.9

ICD-10 Finland

Hypotension, unspecified

4.7

24.6

184

K28

ICPC

Limited function/disability (K)

3.5

24.2

116

338

3A149

NOMESCO Finland

56.3

24.0

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

24.0

279

1359

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

+∞

24.0

FPF00

NOMESCO Finland

Implantation of epicardial pacemaker with ventricular electrode

+∞

24.0

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

+∞

24.0

FPB22

NOMESCO Finland

Transvenous radiofrequency ablation of aberrant pathway or focus of heart

+∞

24.0

AT7

Replacing the pacemaker VVI (R) S

+∞

24.0

AC4

MVP

+∞

24.0

Q23.11

ICD-10 Finland

Bicuspid aortic valve

25.5

23.9

B01AB04

ATC

dalteparin; parenteral

2.3

23.8

221

973

TFP59

NOMESCO Finland

Ablation treatment of other ventricular tachycardia

87.1

23.7

I40.0

ICD-10 Finland

Infective myocarditis

241.0

23.7

A12AA04

ATC

calcium carbonate; oral

4.4

23.6

201

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.4

23.6

206

879

ZX197

NOMESCO Finland

41.6

23.6

J96.0

ICD-10 Finland

Acute respiratory failure

5.1

23.5

149

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.4

23.4

207

888

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

23.4

834

5780

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

23.4

1560

12264

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

23.3

382

2130

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.7

23.1

104

288

R18

ICD-10 Finland

Ascites

3.6

23.1

107

304

E66.9

ICD-10 Finland

Obesity, unspecified

3.1

23.0

127

412

AR6

Catheter ablation of arrhythmia, target: atrial fibrillation

+∞

22.9

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

+∞

22.9

120

NOMESCO Finland

65.2

22.8

I45.6

ICD-10 Finland

Pre-excitation syndrome

40.2

22.6

WW200

NOMESCO Finland

Immunization

2.9

22.6

138

479

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.4

22.6

187

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.4

22.4

192

811

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

22.3

278

1396

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

22.2

1336

10289

FXG00

NOMESCO Finland

Insertion and use of IABP

24.0

22.1

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

21.9

699

4713

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

21.9

1183

8927

FN2EG

NOMESCO Finland

Catheter-based alcohol septal ablation

+∞

21.9

4240A

ICD-9 Finland

Other diseases of endocardium, Mitral valve disorders[INSUFFICIENTIA VALVULAE MITRALIS (NON RHEUMATICA)]

+∞

21.9

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

+∞

21.9

FA1AC

NOMESCO Finland

Upper cavography

62.7

21.8

A28

ICPC

Limited function/disability NOS

1.6

21.8

600

3902

SPAT1254

SPAT

Administration of medicine

1.6

21.7

558

3565

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

21.5

304

1604

PD5BD

NOMESCO Finland

Extensive CT of aorta

3.8

21.5

250

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

21.5

191

822

SPAT1325

SPAT

Vaccination

1.4

21.2

1452

11424

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.4

21.2

189

814

RS221

NOMESCO Finland

4.2

21.2

195

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

21.1

269

1364

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

10.3

21.0

I51.4

ICD-10 Finland

Myocarditis, unspecified

9.0

21.0

G93.1

ICD-10 Finland

Anoxic brain damage, not elsewhere classified

11.9

21.0

R4190

NOMESCO Finland

Nutritional therapy

2.6

21.0

154

600

4270A

ICD-9 Finland

Cardiac dysrhythmias, Paroxysmal supraventricular tachycardia

+∞

20.8

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

18.3

20.4

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

4.5

20.3

161

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.9

20.2

128

456

J94.8

ICD-10 Finland

Other specified pleural conditions

3.9

20.1

220

42798

ICD-8 Finland

Symptomatic heart disease, Alia arrhytmia definita

6.7

20.1

E86

ICD-10 Finland

Volume depletion

3.0

19.9

117

398

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

2.9

19.9

120

414

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

19.8

1199

9207

FN1AD

NOMESCO Finland

CT of coronary arteries

4.2

19.8

179

FPH20

NOMESCO Finland

Removal of epicardial pacemaker or cardioverter-defibrillator

+∞

19.8

FLE10

NOMESCO Finland

Myotomy or myectomy of left ventricle for outlet obstruction

+∞

19.8

C01EB17

ATC

ivabradine; oral

+∞

19.8

I13.2

ICD-10 Finland

Hypertensive heart and renal disease with both (congestive) heart failure and renal failure

+∞

19.8

AR8

Catheter ablation of arrhythmia, target: left ventricular tachycardia

+∞

19.8

SPAT1262

SPAT

Handing over of treatment supplies

1.5

19.6

792

5625

Z95.9

ICD-10 Finland

Presence of cardiac and vascular implant and graft, unspecified

16.4

19.6

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.8

19.6

130

478

XX3BW

NOMESCO Finland

105.4

19.6

L04AD01

ATC

ciclosporin; systemic

3.4

19.5

287

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.7

19.5

140

536

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

6.4

19.5

C10AA03

ATC

pravastatin; oral

1.8

19.5

322

1795

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.4

19.5

159

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

19.5

311

1717

A10BJ02

ATC

liraglutide; parenteral

3.0

19.4

114

387

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.2

19.4

178

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

19.2

406

2449

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

19.2

982

7305

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

7.2

19.2

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.9

19.1

288

1556

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.2

19.0

201

941

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.3

19.0

178

789

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

4.9

18.9

128

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

18.9

1921

16010

XG466

NOMESCO Finland

Sleep oxymetry

2.5

18.9

150

608

K22

ICPC

Risk factor cardiovascular disease

2.1

18.9

217

1055

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

+∞

18.8

FKC20

NOMESCO Finland

Plastic repair of mitral valve leaflet for insufficiency

+∞

18.8

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

+∞

18.8

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

18.7

1161

8942

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.3

18.6

J01FA06

ATC

roxithromycin; oral

1.3

18.6

1543

12466

XA800

NOMESCO Finland

Neuropsychological investigation

2.3

18.6

181

818

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

4.3

18.5

158

TFP51

NOMESCO Finland

Ablation treatment of idiopathic left ventricle tachycardia

190.6

18.5

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.0

18.5

252

1312

L04AA01

ATC

[U] ciclosporin; systemic

3.7

18.3

223

J01DA01

ATC

[U] cefalexin; systemic

1.3

18.2

2554

22242

FCA70

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft

44.1

18.2

C02DE01

ATC

5.8

18.2

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

1.9

18.0

268

1441

ZXA05

NOMESCO Finland

Left side

1.4

18.0

1044

7943

XF620

NOMESCO Finland

Examination of circulation with color method

9.5

17.8

FFM10

NOMESCO Finland

Occlusion or excision of atrial appendage externally with a closing device

+∞

17.7

283

Kela drug reimbursment

Ivabradine

+∞

17.7

2BD01

NOMESCO Finland

22.8

17.7

B01AB10

ATC

tinzaparin; parenteral

1.9

17.6

267

1447

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

17.6

652

4540

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

95.3

17.6

WX890

NOMESCO Finland

Intesive care monitoring

5.3

17.5

101

WX900

NOMESCO Finland

Resuscitation

8.3

17.4

B03XA02

ATC

darbepoetin alfa; parenteral

3.2

17.3

287

L04AX01

ATC

azathioprine; systemic

2.2

17.3

172

786

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

5.5

17.1

R03BA02

ATC

budesonide; inhalant

1.5

17.1

611

4219

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

4.8

17.1

121

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.5

17.0

130

520

UJF32

NOMESCO Finland

Coloscopy

1.4

17.0

1024

7831

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

17.0

293

1658

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

16.9

267

1468

WX110

NOMESCO Finland

Local anesthesy

1.3

16.9

2733

24145

R4120

NOMESCO Finland

Occupational therapy

1.9

16.9

249

1337

I51.3

ICD-10 Finland

Intracardiac thrombosis, not elsewhere classified

25.6

16.9

5CM18

NOMESCO Finland

9.0

16.8

M10.3

ICD-10 Finland

Gout due to impairment of renal function

9.5

16.8

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

4.1

16.8

160

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

4.0

16.7

165

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.6

16.7

128

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

16.7

551

3734

C08CA02

ATC

felodipine; oral

1.7

16.7

388

2407

FPE26

NOMESCO Finland

Implantation of permanent biventricular pacemaker, transvenous route

+∞

16.7

I34.8

ICD-10 Finland

Other nonrheumatic mitral valve disorders

+∞

16.7

FKC61

NOMESCO Finland

Repair of mitral valve insufficiency by a transluminally inserted clip

+∞

16.7

E06.4

ICD-10 Finland

Drug-induced thyroiditis

+∞

16.7

5244

FHL

Heart transplantation

+∞

16.7

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

3.1

16.6

296

3A560

NOMESCO Finland

90.3

16.6

I51.7

ICD-10 Finland

Cardiomegaly

7.1

16.5

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.7

16.5

115

436

AR1

Catheter ablation of arrhythmia, target: AV node reentry activation (AVNRT)

170.4

16.5

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

27.6

16.5

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

27.6

16.5

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.1

16.3

289

A08

ICPC

Swelling

2.3

16.3

147

641

I45.1

ICD-10 Finland

Other and unspecified right bundle-branch block

14.3

16.3

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.6

16.1

116

448

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

16.0

667

4754

I24.0

ICD-10 Finland

Coronary thrombosis not resulting in myocardial infarction

18.5

16.0

160

Kela drug reimbursment

exenatide

2.9

15.9

328

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.0

15.8

305

I95.2

ICD-10 Finland

Hypotension due to drugs

5.8

15.8

TK830

NOMESCO Finland

Ultrafiltration

60.2

15.7

C01BC03

ATC

propafenone; systemic

33.4

15.7

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

15.7

448

2934

ATB

Replacement of biventricular, physiological pacemaker DDD (R) S

+∞

15.6

AC2

MVR bio

+∞

15.6

4260A

ICD-9 Finland

Conduction disorders, Atrioventricular block, complete

+∞

15.6

SPAT1097

SPAT

Recording of ECG

1.5

15.6

559

3859

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.4

15.5

129

A10AE05

ATC

insulin detemir; parenteral

1.9

15.5

220

1165

FPJ02

NOMESCO Finland

Revision of ventricular pacemaker generator

160.4

15.5

J01AA02

ATC

doxycycline; systemic

1.3

15.5

3320

30260

SPAT1260

SPAT

Consultation of another employee

1.5

15.4

650

4639

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.9

15.4

328

A41.8

ICD-10 Finland

Other specified sepsis

3.3

15.3

242

R60.0

ICD-10 Finland

Localized oedema

1.6

15.2

388

2466

R11

ICD-10 Finland

Nausea and vomiting

1.8

15.2

267

1521

WX213

NOMESCO Finland

Lower leg blockade

5.9

15.2

SPAT1251

SPAT

Organisation of medication

2.3

15.2

136

591

SPAT1104

SPAT

Monitoring of emergency patient

1.8

15.2

248

1381

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

15.1

548

3792

T82.7

ICD-10 Finland

Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts

23.4

15.1

FM1EE

SPAT

6.3

15.0

SPAT1285

SPAT

Provision of consultation response

2.0

15.0

205

1071

V03AE01

ATC

polystyrene sulfonate; oral

3.7

14.9

174

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

14.8

258

1467

M01AB05

ATC

diclofenac; systemic, rectal

0.8

14.8

2212

25047

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

3.9

14.7

151

I27.0

ICD-10 Finland

Primary pulmonary hypertension

25.1

14.7

GE1BE

NOMESCO Finland

Mediastinal ultrasound examinaiton through oesophagus

21.1

14.6

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.8

14.6

243

1360

I34.02

ICD-10 Finland

Mitralysis insufficiency caused by ischemia

+∞

14.6

4029B

ICD-9 Finland

Hypertensive heart disease, Unspecified[CUM DECOMPENSATIONE CORDIS (WHO III)]

+∞

14.6

T86.2

ICD-10 Finland

Heart transplant failure and rejection

+∞

14.6

Mitral valve plasty

+∞

14.6

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

14.6

222

1206

5401

FHL

Pacemaker installation, transvenous electrode

80.3

14.6

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

4.0

14.5

143

42508

ICD-8 Finland

Cardiomyopathy, Alia definita

150.3

14.5

E66.0

ICD-10 Finland

Obesity due to excess calories

4.5

14.5

111

A10BB01

ATC

glibenclamide; oral

2.0

14.4

191

987

I44.4

ICD-10 Finland

Left anterior fascicular block

36.1

14.4

I45.0

ICD-10 Finland

Right fascicular block

9.4

14.4

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

6.4

14.4

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

3.7

14.4

174

SPAT1252

SPAT

Overall medication plan or its review

1.7

14.4

279

1643

288

Kela drug reimbursment

Febuxostat

7.5

14.4

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.3

14.3

216

SPAT1081

SPAT

Cardiorespiratory global assessment

1.9

14.3

226

1244

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

14.3

304

1836

Coronary artery bypass surgery

2.5

14.3

108

430

3A422

NOMESCO Finland

27.2

14.3

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

14.1

429

2852

NHQ40

NOMESCO Finland

Amputation of toe

3.2

14.0

225

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

14.0

159

772

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.3

14.0

821

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.1

13.9

134

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

3.0

13.9

269

K04

ICPC

Palpitations/awareness of heart

2.3

13.9

130

577

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

13.9

196

1036

FM1CN

NOMESCO Finland

Heart perfusion isotope imaging at rest

53.4

13.8

FM1AD

NOMESCO Finland

CT of heart

53.4

13.8

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.5

13.7

108

439

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

8.1

13.7

Q21.10

ICD-10 Finland

Persistent ostium secundum

9.7

13.7

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

13.7

405

2675

I11

ICD-10 Finland

Hypertensive heart disease

6.9

13.6

ASX

Other pacemaker insertion

75.3

13.6

FKE60

NOMESCO Finland

Repair of mitral valve regurgitation with transvenously implanted clip

+∞

13.5

FFW96

NOMESCO Finland

Other operation on atria

+∞

13.5

AD1

TVP

+∞

13.5

I31.1

ICD-10 Finland

Chronic constrictive pericarditis

+∞

13.5

3AE00

NOMESCO Finland

+∞

13.5

M04AA03

ATC

febuxostat; oral

7.9

13.5

K07

ICPC

Swollen ankles/oedema

2.2

13.5

143

674

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

13.5

456

3104

AT4

Physiological pacemaker replacement DDD (R)

140.3

13.4

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

13.4

170

864

A02BC01

ATC

omeprazole; systemic

1.3

13.4

1075

8563

4276B

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA VENTRICULARIS]

7.4

13.4

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.1

13.4

228

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.5

13.4

102

R03AC03

ATC

terbutaline; inhalant

1.5

13.4

463

3170

A10BJ06

ATC

semaglutide; parenteral

2.3

13.4

127

571

R1420

NOMESCO Finland

Assessment of rehabilitation needs and/or compilation of rehabilitation plan

18.2

13.3

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

0.5

13.3

134

2442

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

7.2

13.2

K92.1

ICD-10 Finland

Melaena

1.8

13.2

212

1174

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

13.2

225

1271

F1279

NOMESCO Finland

40.1

13.1

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

6.1

13.1

TFN04

NOMESCO Finland

5.5

13.1

ZXA00

NOMESCO Finland

Right side

1.3

13.0

1075

8596

FM1BD

NOMESCO Finland

Extensive CT of heart

8.7

12.9

J20

ICD-10 Finland

Acute bronchitis

1.6

12.9

315

1977

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

1.8

12.9

208

1153

R57.0

ICD-10 Finland

Cardiogenic shock

22.6

12.9

C10AX09

ATC

ezetimibe; oral

1.5

12.8

428

2902

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.3

12.8

117

513

XX3BT

NOMESCO Finland

Other labeling with X-ray guidance

50.1

12.8

5253

FHL

Cardiac lung machine

4.3

12.8

107

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

12.8

122

548

RS222

NOMESCO Finland

3.4

12.7

177

UJF92

NOMESCO Finland

Capsular endoscopy

2.9

12.7

260

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

12.6

418

2830

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.9

12.6

192

1045

42297

ICD-8 Finland

Acute myocarditis, Suspecta

+∞

12.5

4229X

ICD-9 Finland

Acute myocarditis, Other and unspecified acute myocarditis[MYOCARDITIS ACUTA NUD]

+∞

12.5

0034

NOMESCO Finland

+∞

12.5

42728

ICD-8 Finland

Symptomatic heart disease, Dissociatio cordis alia

+∞

12.5

ATA

Biventricular pacemaker replacement VVI (R) S

+∞

12.5

I36.0

ICD-10 Finland

Nonrheumatic tricuspid (valve) stenosis

+∞

12.5

FJA00

NOMESCO Finland

Biopsy of right ventricle

+∞

12.5

XF645

NOMESCO Finland

Heart ultrasound examination with load test

+∞

12.5

AT6

Biventricular physiological heart failure pacemaker replacement DDD (R)

+∞

12.5

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

24.3

12.4

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

12.4

160

818

Aortic Valve Replacement (AVR)

130.3

12.4

T82.1

ICD-10 Finland

Mechanical complication of cardiac electronic device

130.3

12.4

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

12.2

803

6193

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

5.9

12.2

ZZA00

NOMESCO Finland

Split skin graft

2.2

12.2

123

567

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.7

12.2

137

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

15.9

12.1

GD2SN

NOMESCO Finland

Lung ventilation SPECT

5.6

12.0

I97.0

ICD-10 Finland

Postcardiotomy syndrome

11.0

12.0

H02AB04

ATC

methylprednisolone; systemic

1.4

11.9

510

3648

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

11.9

318

2048

EBA10

NOMESCO Finland

Surgical removal of tooth

1.6

11.8

342

2244

349

Kela drug reimbursment

Febuxostat

7.9

11.8

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.0

11.8

157

815

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.2

11.8

194

R06.2

ICD-10 Finland

Wheezing

2.0

11.7

142

711

M10.2

ICD-10 Finland

Drug-induced gout

9.6

11.7

K90

ICPC

Stroke/cerebrovascular accident

2.2

11.7

112

506

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

11.7

260

1596

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.3

11.6

474

NOMESCO Finland

30.1

11.6

B01AC06

ATC

acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)

2.0

11.5

145

737

XW000

NOMESCO Finland

Bone marrow biopsy

1.9

11.5

167

894

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.3

11.5

103

451

FM2CE

NOMESCO Finland

8.6

11.5

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

7.1

11.5

GD1UN

NOMESCO Finland

Lung circulation SPECT

5.9

11.4

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

11.4

428

2977

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.5

11.3

344

4029A

ICD-9 Finland

Hypertensive heart disease, Unspecified[DECOMPENSATIO CORDIS NON INDICATA (WHO II)]

6.0

11.3

J45.8

ICD-10 Finland

Mixed asthma

2.3

11.3

104

460

C09CA06

ATC

candesartan; oral

1.3

11.3

762

5896

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

4.1

11.3

102

Z31.5

ICD-10 Finland

Genetic counselling

2.1

11.3

125

605

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.2

11.2

107

483

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

3.5

11.2

142

M01AC06

ATC

meloxicam; systemic, rectal

0.8

11.2

926

11337

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.0

11.2

144

739

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

2.6

11.2

313

WX402

NOMESCO Finland

General anaesthesia

1.4

11.2

549

4029

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

4.4

11.2

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.6

11.0

302

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.5

11.0

327

L17

ICPC

Foot/toe symptom/complaint

1.3

11.0

873

6916

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

11.0

431

5864

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

2.9

11.0

232

J01CF05

ATC

flucloxacillin; systemic

2.0

11.0

134

673

R07.3

ICD-10 Finland

Other chest pain

1.6

11.0

321

2114

RS230

NOMESCO Finland

5.6

11.0

Z94.0

ICD-10 Finland

Kidney transplant status

3.4

11.0

150

N05CD07

ATC

temazepam; oral

1.4

10.9

499

3610

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

2.5

10.9

342

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

2.3

10.8

101

450

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

0.7

10.8

297

4296

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

10.6

10.7

D86.0

ICD-10 Finland

Sarcoidosis of lung

3.1

10.7

191

FM1BG

NOMESCO Finland

MRI examination of heart with high intensity magnet

28.1

10.7

I45.8

ICD-10 Finland

Other specified conduction disorders

28.1

10.7

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

10.7

2705

24550

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.5

10.7

331

FC1BC

NOMESCO Finland

Extensive angiography of thoracal aortta

21.5

10.7

C61

ICD-10 Finland

Malignant neoplasm of prostate

0.7

10.6

315

4495

I45.5

ICD-10 Finland

Other specified heart block

60.1

10.6

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

10.5

496

3609

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

9.2

10.5

R03.0

ICD-10 Finland

Elevated blood-pressure reading, without diagnosis of hypertension

0.3

10.5

837

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.3

10.4

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.8

10.4

110

I33.9

ICD-10 Finland

Acute endocarditis, unspecified

110.2

10.4

4263A

ICD-9 Finland

Conduction disorders, Other left bundle branch block

+∞

10.4

AM4

VAD (use of the left and / or right side mechanical support (other than IABP)

+∞

10.4

AC1

MVR mechanical

+∞

10.4

FPD00

NOMESCO Finland

Maze procedure for atrial fibrillation

+∞

10.4

354

Kela drug reimbursment

Ivabradine

+∞

10.4

FPD96

NOMESCO Finland

Other operation for atrial fibrillation

+∞

10.4

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

+∞

10.4

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

10.4

251

1576

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

5.4

10.4

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

4.7

10.4

EBA00

NOMESCO Finland

Extraction of tooth

1.3

10.4

1228

10248

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

3.0

10.4

190

M79.6

ICD-10 Finland

Pain in limb

1.3

10.4

1214

10118

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

2.3

10.4

390

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

3.8

10.3

111

SPAT1301

SPAT

No procedures

1.3

10.3

1175

9763

SPAT1211

SPAT

Application of soft bandage

1.5

10.3

311

2065

T14.5

ICD-10 Finland

Injury of blood vessel(s) of unspecified body region

6.0

10.2

SPAT1229

SPAT

Assessment of need for aid

1.6

10.2

265

1695

3A077

NOMESCO Finland

23.4

10.2

R42

ICD-10 Finland

Dizziness and giddiness

1.3

10.2

753

5901

PD5AD

NOMESCO Finland

CT of aorta

3.0

10.2

187

SPAT1310

SPAT

Counselling related to known health issue

1.3

10.2

1151

9549

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.1

10.2

112

541

K79

ICPC

Paroxysmal tachycardia

7.4

10.1

FN1BD

NOMESCO Finland

Extensive CT of coronary arteries

13.1

10.1

R05

ICPC

Cough

1.3

10.1

721

5616

A07AA02

ATC

nystatin; oral

1.7

10.1

218

1328

130

Kela drug reimbursment

Malignant tumour

0.6

10.1

190

2965

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

10.0

387

2709

R06

ICPC

Nose bleed/epistaxis

2.5

10.0

300

AN3

Balloon angioplasty and metallic stent

2.0

10.0

124

626

H02AB09

ATC

hydrocortisone; systemic

2.3

10.0

375

JN4DR

NOMESCO Finland

Whole body metabolic PET with CT

10.0

Q21.19

ICD-10 Finland

Atrial septal defect NOS

14.6

10.0

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.2

9.9

439

V03AE02

ATC

sevelamer; oral

5.8

9.9

40299

ICD-8 Finland

Hypertensive heart disease

5.5

9.9

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.2

9.9

419

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

3.4

9.9

136

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

9.9

445

3210

N05BA04

ATC

oxazepam; oral

1.3

9.8

827

6600

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.4

9.8

137

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

9.8

291

1925

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.3

9.8

148

FWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of heart and major thoracic vessels

20.0

9.8

PC1BD

NOMESCO Finland

Extensive CT of thoracic aorta

7.0

9.8

K08.3

ICD-10 Finland

Retained dental root

1.6

9.7

273

1780

NGQ20

NOMESCO Finland

Amputation of lower leg

5.1

9.7

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

9.6

585

4444

TFP33

NOMESCO Finland

Simple electrophysiological investigation (e.g. ventricular stimulation)

55.1

9.6

I46.1

ICD-10 Finland

Sudden cardiac death, so described

55.1

9.6

XG460

NOMESCO Finland

Short time oxymetry

2.5

9.6

296

A04

ICPC

Weakness/tiredness general

1.5

9.6

377

2651

RS220

NOMESCO Finland

3.0

9.6

187

R03BA05

ATC

fluticasone; inhalant

1.4

9.6

580

4404

K05

ICPC

Irregular heartbeat other

2.4

9.6

326

Z82.7

ICD-10 Finland

Family history of congenital malformations, deformations and chromosomal abnormalities

8.4

9.5

K06.18

ICD-10 Finland

Another gingival hyperplasia

5.7

9.5

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

4.8

9.4

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

9.4

579

4407

211

AVR mechanical

100.2

9.4

AT8

Physiological pacemaker replacement DDD (R) S

100.2

9.4

Z94.3

ICD-10 Finland

Heart and lungs transplant status

100.2

9.4

APS

Ventricular septal alcohol ablation (septic vascular embolization)

100.2

9.4

WW500

NOMESCO Finland

Blood transfusion

1.8

9.4

152

850

FGE10

NOMESCO Finland

Replacement of tricuspid valve using biological prosthesis

+∞

9.4

4241A

ICD-9 Finland

Other diseases of endocardium, Aortic valve disorders[INSUFFICIENTIA VALVULAE AORTAE (NON RHEUMATICA)]

+∞

9.4

FFM32

NOMESCO Finland

Occlusion or excision of atrial appendage transvenously with a closing device

+∞

9.4

5409

FHL

Other measure in this category

+∞

9.4

FPJ01

NOMESCO Finland

Revision of atrial pacemaker generator

+∞

9.4

Mitral valve Replacement (MVR)

+∞

9.4

I40.1

ICD-10 Finland

Isolated myocarditis

+∞

9.4

Heart transplantation

+∞

9.4

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

2.3

9.4

352

132

Kela drug reimbursment

Sarcoidosis

3.8

9.4

101

I95.1

ICD-10 Finland

Orthostatic hypotension

1.9

9.4

124

647

WX870

NOMESCO Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1802

7336

3.17

320.98

6.5

3.0

597.7

507.0

ng/l

0.30

1691

5789

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

619

966

7.10

307.65

6.3

2.6

0.4

u/ml

0.24

384

514

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2188

9649

3.11

307.65

2.9

2.0

3.0

2.8

mg/l

2.95

1957

8021

(3032080) INR in Blood by Coagulation assay

3183

16110

3.32

307.65

23.1

4.6

1.6

1.1

inr

90.49

912

4277

(3022948) Iron [Moles/volume] in Serum or Plasma

2197

5634

5.83

307.65

3.5

2.2

13.5

13.7

umol/l

0.62

2101

5180

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1699

2643

8.86

307.65

5.9

1.9

429.2

89.5

ng/l

74.90

1646

2331

(3020779) Urea [Moles/volume] in Serum or Plasma

1278

3372

4.64

307.65

16.8

6.3

12.4

9.3

mmol/l

32.69

1227

3200

(3022217) INR in Platelet poor plasma by Coagulation assay

1554

3904

5.16

307.65

45.7

10.2

1.8

1.1

inr

29.22

182

704

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2080

4823

6.33

307.65

3.6

2.3

22.8

24.3

4.49

1881

4039

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2867

14794

2.96

307.65

4.0

2.5

183.4

167.9

ug/l

0.84

2723

13436

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3910

9889

11.27

307.65

8.3

1.9

2672.7

637.3

ng/l

88.11

3742

8057

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1678

6130

3.50

307.65

7.7

3.4

0.8

mmol/l

0.96

1592

5701

(3027456) Digoxin [Moles/volume] in Serum or Plasma

557

85.99

307.65

3.1

1.8

0.8

nmol/l

0.42

430

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2119

5194

6.02

307.65

3.5

2.2

2.3

g/l

3.97

2020

4776

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1357

5034

3.25

278.17

9.1

5.4

1.1

1.0

mmol/l

23.13

1279

4689

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

497

880

6.11

270.87

2.1

1.7

10.8

11.0

mg/l

0.22

452

817

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

977

3037

3.70

263.92

3.4

1.9

19.0

6.5

ug/l

9.43

906

2581

(3000991) Gas panel - Venous blood

976

3115

3.59

252.63

16.4

7.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

651

1597

4.49

243.25

4.1

3.3

4.2

4.5

pmol/l

12.00

603

1411

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2702

15278

2.51

238.52

6.2

2.9

101.1

90.1

ng/l

0.08

2259

10938

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1143

4418

3.00

212.73

13.7

6.4

5.0

5.1

kpa

1.84

1081

4213

(3027801) Oxygen [Partial pressure] in Arterial blood

1142

4418

3.00

212.16

13.6

6.4

11.1

12.6

kpa

21.31

1077

4213

(3003396) Base excess in Arterial blood by calculation

1136

4401

2.99

210.36

13.7

6.4

0.7

0.9

mmol/l

0.87

895

3363

(3002032) Base excess in Venous blood by calculation

994

3578

3.17

209.21

6.5

3.5

1.7

mmol/l

0.04

814

2841

(3021447) Carbon dioxide [Partial pressure] in Venous blood

990

3595

3.14

204.97

6.5

3.5

5.9

5.8

kpa

2.56

958

3506

(3023368) Bacteria identified in Blood by Culture

2138

11497

2.41

202.28

5.9

3.9

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

578

1524

4.12

194.94

2.1

1.7

32.1

39.3

u/l

9.08

386

1362

(3016502) Oxygen saturation in Arterial blood

1031

3980

2.96

190.59

14.7

6.8

94.7

95.9

5.13

1002

3824

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

614

1726

3.88

189.19

7.3

4.0

23.8

23.9

mmol/l

0.26

571

1552

(3014111) Lactate [Moles/volume] in Serum or Plasma

902

3279

3.10

185.12

15.2

6.3

1.5

1.3

mmol/l

4.01

856

3149

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1280

5831

2.56

169.38

6.1

1.9

32.4

29.2

38.97

1252

5668

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

566

1673

3.66

161.19

1.8

1.6

1.5

1.6

g/l

0.77

493

1423

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1077

4624

2.65

160.12

8.8

4.4

260.1

239.5

u/l

3.12

1024

4354

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1329

6329

2.45

158.64

2.1

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3172

21472

2.13

157.71

9.8

6.4

14.9

11.9

umol/l

21.53

3055

20379

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2863

18707

2.11

155.57

11.8

5.3

1.2

mmol/l

44.12

2684

16733

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

622

2016

3.35

153.25

18.5

8.4

24.0

24.2

mmol/l

0.64

576

1885

(3002173) Hemoglobin [Mass/volume] in Arterial blood

907

3647

2.78

152.88

16.1

7.2

123.1

123.4

g/l

0.18

889

3499

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3073

20720

2.10

152.27

12.4

6.0

1.2

mmol/l

52.87

2640

17431

(3014576) Chloride [Moles/volume] in Serum or Plasma

1132

5092

2.54

152.13

13.9

6.3

103.9

104.5

mmol/l

2.79

1109

4984

(3042733) HLA Ab [Presence] in Serum

136

101

13.78

146.04

4.6

4.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

388

942

4.36

145.08

5.9

2.6

3.7

3.6

g/l

0.28

370

905

(3026250) Tacrolimus [Mass/volume] in Blood

157

149

10.82

144.42

38.8

32.5

7.8

7.3

ug/l

1.37

147

134

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

982

4294

2.57

138.94

2.0

1.7

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

643

2265

3.08

137.23

17.4

6.4

24.3

24.8

mmol/l

2.00

638

2244

(3013826) Glucose [Moles/volume] in Serum or Plasma

3441

24753

2.05

136.09

10.0

4.1

7.0

6.8

mmol/l

5.39

3307

23096

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

973

4297

2.54

134.48

2.0

1.6

—

(3018418) pH of Serum or Plasma

2009

11995

2.06

133.60

5.8

3.8

7.4

0.76

401

2202

(3042936) Bacteria identified in Isolate by Culture

1164

5609

2.36

132.60

2.7

1.9

—

(3003434) Protein [Mass/volume] in Pleural fluid

228

391

6.04

127.22

1.5

1.3

26.6

37.7

g/l

24.43

188

363

(3001604) Monocytes [#/volume] in Blood

2901

19962

1.96

126.47

8.3

5.7

0.7

0.6

e9/l

10.77

2527

17018

(3024354) Oxygen [Partial pressure] in Venous blood

741

2956

2.74

125.29

5.7

3.0

4.6

4.5

kpa

0.68

709

2875

(3006315) Basophils [#/volume] in Blood

2907

20062

1.95

125.14

8.3

5.7

0.0

e9/l

0.34

2536

17133

(3013115) Eosinophils [#/volume] in Blood

2979

20749

1.95

124.56

8.9

5.9

0.2

e9/l

3.37

2615

17951

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

449

1356

3.52

122.85

4.6

2.1

886.5

688.7

ug/l

0.22

434

1277

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1466

7990

2.14

122.41

5.7

1.6

1.4

mg/l

1.32

1182

6228

(3024561) Albumin [Mass/volume] in Serum or Plasma

2680

18105

1.94

121.77

6.0

4.8

34.0

35.4

g/l

29.20

2532

16717

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

359

937

4.03

121.49

6.2

2.5

217.0

190.2

6.60

350

890

(3028308) Erythrocytes [#/volume] in Pleural fluid

208

341

6.30

121.42

1.5

1.3

30527.8

77730.4

e6/l

1.63

134

198

(3023199) Leukocytes [#/volume] in Pleural fluid

219

379

5.98

121.03

1.5

1.3

5581.6

3105.0

e6/l

0.24

154

270

(42870588) Differential panel, method unspecified - Blood

2180

13798

1.96

119.64

8.3

5.8

—

(3019198) Lymphocytes [#/volume] in Blood

2937

20545

1.92

119.17

8.4

5.8

1.8

2.0

e9/l

4.54

2585

17867

(3012441) Differential panel - Pleural fluid

197

312

6.51

118.95

1.4

1.3

—

(3045788) Cell count panel - Pleural fluid

187

290

6.64

115.21

1.6

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

373

1043

3.76

114.37

7.8

2.2

86.7

90.6

2.68

364

981

(3020630) Protein [Mass/volume] in Serum or Plasma

792

3409

2.55

114.23

2.1

2.5

64.3

67.0

g/l

16.36

736

3048

(3026493) Urate [Moles/volume] in Serum or Plasma

1854

11289

1.97

112.32

3.6

2.6

2907.2

5681.9

umol/l

2.74

1628

9727

(3022096) Basophils/100 leukocytes in Blood

2666

18296

1.89

112.31

8.7

6.0

0.6

0.7

4.11

2548

16921

(3036489) Thrombin time

415

1277

3.43

110.02

5.9

2.1

22.7

21.2

2.31

394

1133

(3006504) Eosinophils/100 leukocytes in Blood

2712

18822

1.87

109.23

8.7

5.9

2.7

3.0

9.06

2594

17388

(3027945) Reticulocytes/100 erythrocytes in Blood

960

4603

2.32

108.57

2.7

2.4

1.9

1.7

7.78

867

4014

(3019069) Monocytes/100 leukocytes in Blood

2718

18936

1.86

107.57

8.9

6.3

9.2

8.9

4.41

2604

17560

(3021589) Normoblasts [#/volume] in Blood

2612

18058

1.85

105.12

14.2

9.0

0.0

e9/l

0.12

2161

14746

(3002030) Lymphocytes/100 leukocytes in Blood

2755

19438

1.84

103.10

8.8

6.0

23.6

27.7

67.06

2630

17914

(40758558) Short blood count panel - Blood

1673

10111

1.94

101.57

9.4

7.0

—

(3024928) Oxygen saturation in Venous blood

270

652

4.30

101.21

6.4

3.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1988

12774

1.87

99.59

3.6

3.3

46.9

35.9

u/l

1.39

1883

12019

(3022493) Free Hemoglobin [Mass/volume] in Plasma

120

133

9.20

98.54

37.9

1.4

77.5

84.0

mg/l

0.16

107

(3018010) Neutrophils/100 leukocytes in Blood

2702

19137

1.81

98.09

8.6

5.8

60.9

57.1

48.04

2584

17746

(3033658) Prothrombin time (PT) actual/Normal

1712

10530

1.91

97.88

6.8

3.7

69.9

91.7

146.60

1669

10303

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

221

468

4.88

97.55

9.6

6.1

11.1

11.4

mg/l

0.42

200

435

(3019060) Gas panel - Arterial blood

613

2517

2.62

96.64

6.5

4.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

296

793

3.89

96.29

2.6

2.8

32.1

36.7

umol/l

1.71

252

663

(3044889) 12 lead EKG panel

3776

29846

1.85

92.56

7.6

3.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

124

155

8.16

92.53

21.7

26.7

122.2

119.0

ug/l

0.15

133

(3013650) Neutrophils [#/volume] in Blood by Automated count

3126

23431

1.78

90.75

11.1

9.2

4.5

4.2

e9/l

13.12

2753

20344

(3024932) HLA-DR beta [Type]

107

116

9.39

89.33

1.0

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

790

3769

2.28

89.09

2.2

2.3

0.2

g/l

9.58

721

3520

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

541

2172

2.65

88.97

22.1

8.4

—

(3024471) HLA-A [Type]

107

117

9.31

88.75

1.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

897

4515

2.18

88.66

2.4

1.6

—

(40768806) Pleura Pathology biopsy report

173

326

5.45

87.22

1.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1917

12581

1.80

86.83

2.9

2.1

257.9

237.4

u/l

0.32

1830

11761

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

607

2661

2.44

82.76

1.7

1.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

550

2335

2.51

80.29

5.7

2.9

128.7

130.3

g/l

0.75

530

2281

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

164

318

5.29

80.09

2.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

160

308

5.32

78.77

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

154

289

5.45

77.97

1.3

6.8

5.6

mmol/l

3.37

144

256

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

261

747

3.62

76.96

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

261

747

3.62

76.96

1.4

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

102

127

8.16

76.34

2.5

1.8

191.8

151.7

3.79

117

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

327

1084

3.14

76.29

1.7

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

235

630

3.85

76.23

1.8

1.5

123.6

107.9

u/ml

1.82

128

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

252

713

3.66

75.58

1.7

1.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3975

32844

1.76

73.33

11.5

7.4

83.0

79.1

u/l

4.54

3820

30734

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

854

4510

2.06

73.32

2.9

10.0

9.4

umol/l

0.38

768

3993

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

232

637

3.76

72.70

1.6

1.3

294.4

263.9

u/ml

0.90

176

398

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

15.05

72.49

1.4

1.3

4.1

492113.4

nmol/l

0.49

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

252

742

3.51

71.14

10.6

5.7

1159.6

2693.0

iu/ml

0.34

113

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

197

495

4.09

69.90

1.5

1.2

3.1

3.9

u/ml

0.52

104

216

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

199

510

4.01

68.72

1.5

1.2

3.1

4.5

u/ml

0.37

156

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

584

2724

2.28

68.54

5.7

3.8

132.5

83.7

ng/l

16.13

531

2354

(3008152) Bicarbonate [Moles/volume] in Arterial blood

541

2453

2.34

67.82

10.0

6.0

24.1

24.5

mmol/l

1.13

512

2259

(1616796) Gas panel - Central venous blood

262

815

3.33

67.82

4.6

3.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

157

339

4.74

67.64

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

237

693

3.53

67.60

1.6

1.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

281

915

3.18

67.47

5.2

3.0

8.1

8.2

kpa

0.32

267

848

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

573

2669

2.28

67.42

5.2

3.2

5.1

kpa

0.04

538

2465

(3027315) Oxygen [Partial pressure] in Blood

260

810

3.32

67.13

5.6

3.5

8.1

8.7

kpa

4.98

255

790

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

552

2540

2.30

66.83

5.1

3.2

2.0

1.4

mmol/l

2.07

394

1842

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

421

1716

2.57

66.57

5.4

2.4

0.6

0.7

1.50

412

1629

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

140

278

5.14

66.55

1.3

533.5

715.7

u/l

0.21

133

259

(3023520) Reticulocytes [#/volume] in Blood

688

3473

2.12

66.19

2.7

2.5

74.2

66.1

e9/l

5.09

509

2655

(3009343) pH of Capillary blood

562

2631

2.27

65.25

5.2

3.2

7.4

1.82

277

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

512

2347

2.30

62.39

1.8

1.6

—

(36304419) Bacteria [Presence] in Urine

1706

11686

1.67

61.37

3.5

3.1

—

(3052851) Hemolysis interference index of Serum or Plasma

307

1110

2.87

61.27

5.9

3.2

—

(3030467) Casts [#/volume] in Urine by Automated count

1764

12209

1.66

60.84

3.6

3.1

0.8

0.4

e6/l

2.48

1401

9215

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

388

1588

2.55

60.71

2.3

1.8

5.7

2.2

ug/l

0.48

354

1405

(3027273) Bicarbonate [Moles/volume] in Venous blood

448

1960

2.40

60.70

4.6

2.9

24.7

25.0

mmol/l

1.23

429

1906

(3002582) Erythrocytes [#/volume] in Urine

1894

13361

1.64

60.48

3.7

3.2

95.3

94.6

e6/l

0.01

1528

10328

(3010421) pH of Blood

273

943

2.99

59.15

5.5

3.3

7.4

0.58

241

791

(4306422)

184

501

3.77

58.33

1.5

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

108

191

5.75

58.28

1.3

1.2

—

(3012501) Base excess in Blood by calculation

246

810

3.13

57.91

5.5

3.4

2.4

mmol/l

0.03

154

538

(3013290) Carbon dioxide [Partial pressure] in Blood

246

810

3.13

57.91

5.6

3.5

4.8

5.0

kpa

1.91

241

791

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

158

388

4.16

57.81

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

257

869

3.05

57.80

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

486

2251

2.27

57.64

1.5

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

1391

9155

1.70

57.58

2.9

2.5

4.6

4.0

e6/l

1.08

1261

7969

(3017143) Hepatitis C virus Ab [Presence] in Serum

675

3559

2.02

57.27

1.8

1.5

—

(3021901) Oxygen saturation in Capillary blood

224

707

3.26

56.58

3.6

2.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

280

1007

2.88

56.39

4.1

2.8

24.0

24.5

mmol/l

0.90

249

885

(3020891) Body temperature

363

1490

2.54

56.38

6.3

4.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

185

518

3.66

56.29

1.4

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

236

779

3.12

55.31

3.1

2.3

16.4

16.8

0.67

130

419

(3048929) Epstein Barr virus Ab [Presence] in Serum

265

947

2.89

53.98

1.5

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

707

3869

1.95

53.72

1.8

1.5

—

(3035880) pH of Pleural fluid

161

5.99

53.58

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

319

1265

2.62

53.16

2.6

3.1

42.5

49.3

mg/l

0.38

259

1040

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

10.86

53.03

1.6

1.2

82.0

81.4

0.03

(3009871) Measles virus Ab [Titer] in Serum

103

7.47

52.93

1.2

1.7

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

319

1268

2.61

52.90

2.7

3.1

57.9

94.7

mg/l

0.39

260

1044

(3018095) Leukocytes [#/volume] in Urine

2057

15165

1.57

52.72

4.2

3.6

82.7

94.5

e6/l

0.29

1583

11012

(46235355) HIV 1 and 2 tests - Meaningful Use set

811

4685

1.86

52.11

1.9

1.6

—

(3044640) Blood type and Crossmatch panel - Blood

1810

13056

1.58

50.47

3.3

2.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

309

1239

2.58

50.31

2.6

3.1

1.9

2.5

ratio

0.30

100

(3006184) Hemoglobin [Mass/volume] in Capillary blood

246

888

2.85

49.16

2.6

2.0

131.0

132.0

g/l

0.20

169

639

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

280

1082

2.67

49.11

1.2

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

675

3743

1.92

49.05

2.4

2.5

39.0

71.5

u/l

0.82

581

3245

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

10.69

48.82

1.5

1.2

80.0

71.9

0.49

(3021879) Hepatitis B virus core Ab [Presence] in Serum

477

2345

2.13

48.52

1.6

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1447

9986

1.61

48.26

3.2

2.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

237

855

2.85

47.41

1.6

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

111

243

4.64

47.06

1.2

11.8

16.6

u/l

0.58

226

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

244

907

2.77

46.13

1.4

1.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

268

1047

2.64

45.97

1.3

1.4

15.6

14.5

iu/ml

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

230

832

2.84

45.77

1.6

1.7

—

(3043409) Potassium [Moles/volume] in Arterial blood

282

1134

2.57

45.60

5.9

3.6

4.0

3.9

mmol/l

5.90

266

1062

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3434

28823

1.51

45.16

4.5

3.4

15.5

14.8

pmol/l

34.50

3175

25629

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

268

1064

2.60

44.49

5.8

3.9

1.9

1.4

mg/l

16.31

251

966

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

293

1216

2.49

44.33

1.9

2.1

0.0

0.1

g/l

1.68

267

1099

(4268621)

129

332

3.95

44.31

3.1

2.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

274

1107

2.55

43.87

1.9

2.1

0.0

g/l

0.00

249

1010

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

344

1550

2.30

43.28

1.8

2.1

10.1

10.2

g/l

0.13

302

1266

(3004588) Protein electrophoresis panel - Serum or Plasma

543

2917

1.96

43.10

2.0

2.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

275

1124

2.52

42.97

1.9

2.1

0.0

g/l

0.79

249

1013

(3026782) Osmolality of Urine

1267

8674

1.60

42.88

3.0

2.7

530.2

583.9

mosm/kgh2o

17.38

1118

7351

(3051651) Icteric interference index of Serum or Plasma

100

217

4.68

42.87

8.6

3.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

343

1553

2.29

42.65

1.9

2.2

3.2

3.0

g/l

2.94

290

1178

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

317

1392

2.36

42.32

2.5

2.7

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

118

6.17

42.03

2.3

1.9

5426.0

2599.6

e6/l

1.15

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

357

1656

2.24

41.88

1.8

2.1

3.7

3.9

g/l

1.17

285

1154

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

357

1660

2.23

41.63

1.8

2.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

357

1661

2.23

41.57

1.8

2.1

7.3

g/l

0.03

292

1205

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

174

572

3.11

41.06

4.9

3.0

4801.6

3507.5

u/ml

0.11

(3034426) Prothrombin time (PT)

112

6.23

40.67

1.6

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

295

1277

2.38

40.67

1.5

100.0

248.7

titre

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

9.49

40.63

1.3

43.5

262.3

ng/l

0.94

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

296

1291

2.37

40.11

1.9

2.0

35.7

38.5

g/l

10.14

256

1069

(3037522) Nuclear Ab [Titer] in Serum

758

4618

1.74

39.98

1.3

420.5

519.5

titre

0.83

133

892

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

701

4194

1.77

39.35

4.6

3.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

197

712

2.83

39.27

1.4

1.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1748

13062

1.50

39.05

3.1

2.5

61.6

59.8

u/l

0.36

1653

12043

(3023487) Leukocytes [#/volume] in Peritoneal fluid

137

5.46

38.09

2.5

2.1

540.4

1532.2

e6/l

0.66

102

(3021960) Folate [Moles/volume] in Serum or Plasma

1392

9964

1.53

37.97

1.7

1.5

19.1

20.0

nmol/l

1.31

1254

8426

(40760888) Immunoglobulin light chains.free panel - Serum

235

946

2.55

37.89

2.7

3.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

309

1413

2.26

37.48

1.9

2.2

0.5

1.0

g/l

2.23

271

1177

(3024891) Influenza virus A+B Ag [Presence] in Specimen

214

831

2.64

37.14

1.2

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

177

631

2.87

36.20

1.6

1.7

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

7.34

35.15

6.5

6.8

—

(3022313) Gas panel - Capillary blood

385

1978

2.02

34.51

5.6

3.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

148

496

3.04

33.82

1.5

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

6.25

33.81

1.4

1.5

18.6

9.6

g/l

9.44

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

361

1827

2.04

33.72

5.0

3.5

46.6

46.7

0.03

356

1809

(3026008) Bacteria identified in Urine by Culture

1515

11282

1.47

33.31

3.1

—

(3009508) Creatinine [Moles/volume] in Urine

1840

14252

1.44

32.75

3.4

3.2

7.3

8.1

mmol/l

16.65

1555

11869

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

107

299

3.63

32.74

1.1

1.2

80.0

153.1

titre

1.00

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

109

5.65

32.63

1.2

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2383

19343

1.41

32.54

4.8

3.9

—

(3012516) Albumin [Mass/volume] in Urine

1788

13793

1.44

32.47

3.4

3.2

183.9

368.1

mg/l

2.21

1309

8890

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1084

7574

1.54

32.31

3.1

2.8

1.3

1.1

e6/l

0.79

611

4429

(3038071) Oxygen [Partial pressure] in Mixed venous blood

7.55

31.80

6.3

7.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

6.51

31.48

1.7

1.4

31.8

19.2

g/l

5.56

(3011335) Digoxin [Mass/volume] in Serum or Plasma

+∞

31.27

2.3

0.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3168

27111

1.40

31.13

4.9

4.2

1059.9

1868.3

e6/l

0.38

426

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

166

620

2.73

31.13

1.3

1.4

—

(3033799) Differential panel - Peritoneal fluid

125

5.17

31.09

2.3

1.8

—

(3051611) Lipemic interference index of Serum or Plasma

125

403

3.15

30.55

8.2

2.9

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

221

964

2.35

29.93

1.4

1.2

g/l

0.35

203

910

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

214

922

2.37

29.80

1.4

1.5

0.2

g/l

0.34

195

871

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

124

405

3.11

29.65

1.5

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1022

7170

1.52

29.59

3.2

3.0

2.3

1.6

e6/l

1.76

551

4046

(3020682) Albumin/Creatinine [Ratio] in Urine

1851

14557

1.41

29.48

4.2

4.0

13.5

6.9

mg/mmol

5.57

1317

9342

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

169

656

2.63

29.39

1.2

1.3

17.5

32.4

u/l

2.67

154

558

(44790048)

118

379

3.16

29.03

1.6

1.5

—

(44790047)

118

379

3.16

29.03

1.6

1.5

—

(44790049)

118

379

3.16

29.03

1.6

1.5

—

(44806118)

118

379

3.16

29.03

1.6

1.5

—

(3013512) EKG study

1615

12535

1.41

27.26

7.0

3.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

387

2163

1.85

26.88

1.6

1.9

1.2

1.4

g/l

1.45

361

1933

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

100

5.34

26.78

1.3

54.9

59.6

0.31

(3036481) Cortisol [Moles/volume] in Serum or Plasma

533

3297

1.68

26.02

2.4

393.1

368.2

nmol/l

1.63

505

3049

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

534

3308

1.68

25.92

3.4

2.6

53.5

68.4

ml/min/173m2

16.47

251

1245

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

135

499

2.75

25.87

1.3

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

104

5.14

25.65

1.2

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2176

17868

1.36

25.62

2.2

2.0

92.0

93.3

pmol/l

0.56

1211

9583

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

222

3.69

25.57

1.5

1.2

—

(3006576) Bicarbonate [Moles/volume] in Blood

5.30

25.55

5.9

5.8

25.3

24.5

mmol/l

0.65

(3044007) Cell count panel - Peritoneal fluid

110

4.95

25.05

3.0

1.9

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

232

1114

2.13

24.90

1.4

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

466

2817

1.71

24.74

2.5

2.6

10.6

g/l

0.02

434

2546

(3001893) Eosinophils/100 leukocytes in Pleural fluid

5.65

24.71

1.4

1.2

3.0

3.2

0.04

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

140

543

2.62

24.43

1.3

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1112

8213

1.44

24.30

1.8

1.7

1250.5

1116.2

nmol/l

4.54

883

6042

(3013707) Erythrocyte sedimentation rate by Westergren method

3454

30635

1.34

23.35

5.2

3.9

15.5

11.8

mm/h

30.04

3227

28001

(3015377) Calcium [Moles/volume] in Serum or Plasma

1752

14058

1.36

23.34

3.7

3.6

2.3

2.4

mmol/l

5.42

1524

12110

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

127

482

2.67

23.16

1.3

1.4

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

17.33

22.90

2.9

7.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4047

36833

1.38

22.79

5.5

4.1

2.2

mu/l

0.27

3770

32836

(21494755) Public health laboratory ask at order entry panel

137

3107

0.43

22.31

1.3

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

155

676

2.33

21.07

1.6

1.8

72.0

4.8

iu/l

0.48

216

(3000492) Spirometry study

557

3673

1.57

20.83

1.6

1.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4496

41835

1.41

20.68

29.2

12.9

25.9

26.8

mg/l

1.11

4035

32771

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

188

895

2.14

20.67

1.4

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

308

1740

1.82

20.63

6.2

3.3

24.7

24.6

mmol/l

0.21

292

1596

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1627

19798

0.75

20.57

3.8

4.5

22.8

21.8

1.84

748

10226

(3035947) Staphylolysin Ab [Units/volume] in Serum

160

3.78

19.77

1.2

1.1

3.5

3.3

iu/ml

—

(1761868) Lipid panel - Serum or Plasma

1103

14157

0.72

19.62

3.3

3.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

208

1053

2.01

19.42

1.3

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

304

1748

1.78

19.19

7.8

4.6

1.7

1.6

1.03

288

1632

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

150

3107

0.47

19.14

1.6

1.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

207

1056

2.00

18.92

1.3

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

193

961

2.05

18.87

1.1

1.2

69.5

122.0

titre

0.81

(3021788) Differential panel - Synovial fluid

156

721

2.20

18.51

1.4

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

204

1044

1.99

18.49

1.3

1.1

—

(3014891) Appearance of Pleural fluid

7.84

18.27

1.8

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

295

1706

1.77

18.27

2.2

1.8

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

7.46

18.22

1.3

14.9

10.9

—

(3042631) Mycobacterium sp identified in Specimen

128

549

2.36

18.13

2.2

2.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

295

1720

1.76

17.76

8.0

4.6

0.9

0.81

280

1607

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

+∞

17.71

1.2

0.0

—

(3047181) Lactate [Moles/volume] in Blood

229

1251

1.87

17.10

9.5

5.5

1.5

1.3

mmol/l

1.35

206

1093

(3002385) Erythrocyte distribution width [Ratio]

3736

34137

1.30

16.96

35.6

16.1

14.3

13.7

99.62

3675

33307

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

383

2.59

16.96

1.6

1.7

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

7.53

16.95

1.5

1.1

63.5

75.8

0.69

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2125

24554

0.78

16.90

4.2

5.3

2.7

3.6

ug/l

1.66

1854

22078

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

194

3.27

16.76

1.3

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

194

3.27

16.76

1.3

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

103

415

2.51

16.74

1.6

1.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

146

3.66

16.72

1.8

2.7

—

(3025941) Bacteria identified in Stool by Culture

319

1951

1.67

16.15

1.4

1.2

—

(3037756) Immunofixation for Serum or Plasma

169

856

2.01

15.81

1.3

1.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

7.61

15.68

1.3

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

317

2.68

15.62

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

317

2.68

15.62

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

317

2.68

15.62

1.6

1.7

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

4.64

15.61

1.5

1.2

31.4

18.9

1.17

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

268

1578

1.73

15.61

2.0

1.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

503

3451

1.50

15.57

4.9

3.4

1.2

mmol/l

9.23

465

2984

(3004451) EKG impression Narrative

163

3.40

15.57

1.1

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

144

3.57

15.54

16.0

3.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

129

600

2.18

15.14

4.3

2.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

290

2.71

14.94

1.4

1.5

—

(3003181) Sodium [Moles/volume] in Urine

141

683

2.09

14.92

1.6

1.3

56.4

65.3

mmol/l

1.98

111

543

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

4.32

14.73

1.1

1.2

59.0

87.6

4.00

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

411

2.41

14.67

3.7

3.9

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

299

2.63

14.10

1.1

—

u/ml

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

124

585

2.15

14.07

1.2

1.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

4.26

14.06

1.1

1.2

50.2

87.7

4.97

(3019977) pH of Arterial blood

214

2.92

13.67

2.4

2.3

7.4

0.03

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

188

3.05

13.60

1.2

36.0

20.2

u/l

2.13

152

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

4.24

13.60

1.4

1.3

29.4

24.1

0.40

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

5.87

13.51

1.3

1.1

87.1

777.2

u/l

0.52

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

105

472

2.25

13.44

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1984

0.45

13.36

1.4

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

125

606

2.09

13.24

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1847

15818

1.25

13.15

2.6

2.1

74.8

77.9

nmol/l

4.30

1660

13890

(40760892) CBC W Ordered Manual Differential panel - Blood

1051

8404

1.31

12.99

5.7

4.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

5.34

12.75

8.5

7.3

—

(3023419) Bacteria identified in Sputum by Culture

105

483

2.20

12.73

1.9

2.6

—

(3044941) Cell count panel - Synovial fluid

127

629

2.04

12.72

1.3

—

(44786800) Granulocytes/100 leukocytes in Body fluid

7.06

12.69

1.1

1.3

20.9

40.2

0.77

(3007164) IgA [Mass/volume] in Serum or Plasma

852

6646

1.33

12.51

1.5

1.4

2.7

2.6

g/l

0.93

549

3892

(3017569) Oxygen content in Arterial blood

182

2.99

12.45

2.7

2.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

178

996

1.81

12.40

1.6

16274.0

13757.1

e6/l

0.23

121

707

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

194

2.91

12.30

1.2

131.9

88.0

u/l

1.78

160

(21494890) Protein electrophoresis panel - 24 hour Urine

394

2.31

12.29

1.6

2.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

5.35

12.28

1.4

1.1

0.8

2.5

mmol/l

0.67

(3011544) Albumin [Mass/volume] in Pleural fluid

7.75

12.28

1.0

13.9

22.8

g/l

3.87

(3037467) Urinalysis macro (dipstick) panel - Urine

3158

28812

1.23

11.98

4.8

4.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

8.02

11.88

3.3

3.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

198

2.85

11.87

2.5

1.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

183

2.91

11.73

2.2

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

246

1530

1.64

11.72

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

465

2.15

11.44

9.3

7.1

7.6

mmol/l

0.96

387

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1199

14357

0.79

11.43

2.7

3.2

0.8

ug/l

0.03

851

9873

(44816559) Phosphatidylethanol [Mass/volume] in Blood

132

692

1.93

11.30

1.4

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

4.37

10.96

1.3

1.0

1.5

2.1

mmol/l

1.66

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

5.95

10.85

1.0

14.8

28.0

u/l

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

297

2.41

10.79

1.6

1.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1312

0.40

10.75

1.7

1.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4644

44403

1.30

10.67

40.5

14.6

139.3

139.7

mmol/l

21.49

4572

43127

(3011397) Hemoglobin [Presence] in Urine by Test strip

1138

9403

1.27

10.63

3.9

3.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

3.60

10.61

1.3

2.7

4.6

mmol/l

2.92

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

617

4701

1.35

10.52

1.8

1.7

1.5

2.99

511

4078

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.63

10.46

3.5

6.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

201

2.70

10.44

2.0

2.1

19.1

59.0

umol/l

—

(3000494) Fungus identified in Specimen by Culture

632

4841

1.35

10.40

1.7

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

950

7705

1.28

10.30

3.0

3.4

2.5

2.4

mmol/l

2.21

816

6797

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

6.68

10.17

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

6.09

9.91

2.8

2.1

66.9

51.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

367

2.20

9.86

3.2

2.6

—

(4010399)

410

2960

1.42

9.70

1.5

1.4

—

(3037121) Protein [Mass/volume] in Urine

222

1414

1.59

9.65

2.7

3.5

0.3

g/l

0.08

115

651

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

353

2.20

9.52

1.1

1.2

99.5

66.6

u/l

0.35

228

(40761535) Cells panel - Urine sediment

476

3536

1.38

9.52

4.1

3.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4645

44548

1.28

9.48

40.9

14.8

4.1

4.0

mmol/l

103.31

4570

43211

(3039000) Anion gap in Blood

155

907

1.73

9.36

12.0

6.3

12.1

11.4

mmol/l

1.50

142

804

(3018572) Chloride [Moles/volume] in Blood

155

907

1.73

9.36

12.0

6.3

104.5

105.2

mmol/l

0.85

142

804

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

499

1.98

9.21

1.3

1.5

66.4

58.4

1.14

315

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

245

2.42

9.17

1.3

1.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2884

26450

1.19

9.08

3.8

3.1

77.8

52.4

u/l

20.33

2686

24295

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

127

709

1.81

9.02

1.1

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

105

554

1.91

8.91

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.66

8.81

1.3

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.51

8.78

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

102

541

1.90

8.54

1.2

—

(3025315) Body weight

6.38

8.52

4.3

3.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

211

2.48

8.52

1.3

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

176

2.63

8.50

1.0

1.1

ratio

0.58

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

143

2.81

8.41

1.3

2.5

78.8

141.7

umol/l

1.26

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

268

2.29

8.39

2.0

2.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

108

587

1.86

8.39

1.6

0.8

0.9

g/l

0.47

451

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

213

2.46

8.36

1.3

1.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

7.87

7.99

2.5

3.4

—

(3017181) Myelocytes/100 leukocytes in Blood

467

3559

1.34

7.93

4.5

4.0

0.8

1.0

1.31

179

997

(40761536) Microorganisms panel - Urine sediment

439

3318

1.35

7.88

4.0

3.7

—

(21494815) CD4 cells/100 lymphocytes in Specimen

335

2.10

7.84

1.9

2.3

32.2

42.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

178

1136

1.59

7.75

2.2

2.3

124.9

104.3

ug/min

0.31

692

(3029937) Albumin [Presence] in Urine by Test strip

1263

10876

1.21

7.71

4.4

3.8

0.0

estimate

0.09

440

3488

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

286

2.18

7.63

1.9

2.1

16.8

14.3

0.30

125

(3019832) Treponema pallidum Ab [Presence] in Serum

249

1717

1.47

7.58

1.4

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

102

3.05

7.57

1.2

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

199

2.42

7.56

1.7

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

199

2.42

7.56

1.7

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

199

2.42

7.56

1.7

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

199

2.42

7.56

1.7

1.9

—

(40768800) Prostate Pathology biopsy report

101

1759

0.57

7.51

1.1

1.2

—

(4281824)

297

2.13

7.36

1.4

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

306

2.10

7.22

1.1

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

7.70

7.12

1.4

1.0

—

(4062490)

357

2.00

7.01

1.4

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

462

1.88

7.00

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

358

2.00

6.96

1.4

1.3

7.2

6.8

g/l

0.37

249

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

3.39

6.96

2.2

1.9

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.22

6.96

1.6

2.2

—

(3011412) CD3 cells [#/volume] in Blood

365

1.99

6.95

2.5

0.9

1.2

e9/l

1.57

220

(4035726)

496

3888

1.30

6.91

2.2

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

113

663

1.72

6.87

1.2

161.7

204.5

miu/ml

0.65

247

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

409

1.92

6.84

1.2

1.8

1.4

nmol/l

1.86

366

(3000060) B lymphocytes [#/volume] in Blood

2.97

6.79

2.3

2.5

178.5

798.2

e6/l

0.73

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

191

2.37

6.77

3.2

3.8

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

294

2.09

6.76

1.0

1.1

305.1

272.2

mg/l

2.38

270

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

5.43

6.76

3.2

2.1

4.3

23.3

—

(40768797) Stomach Pathology biopsy report

687

5623

1.25

6.75

1.2

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

436

3376

1.32

6.65

4.5

4.1

0.1

0.57

162

929

(3024139) IgG subclass 3 [Mass/volume] in Serum

358

1.97

6.61

1.4

1.3

0.5

0.4

g/l

0.65

246

(3028192) IgG subclass 2 [Mass/volume] in Serum

358

1.97

6.61

1.4

1.3

2.9

3.2

g/l

0.77

249

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4181

40052

1.18

6.46

29.1

12.4

70.5

79.0

ml/min/173m2

92.13

3773

32726

(3045716) Anion gap in Serum or Plasma

196

2.31

6.41

3.1

1.8

9.4

9.5

mmol/l

0.06

154

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

455

1.84

6.38

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

291

2.04

6.19

1.3

1.5

24.8

26.9

u/ml

—

(3002179) Metamyelocytes/100 leukocytes in Blood

415

3227

1.31

6.15

4.5

3.9

0.6

0.7

0.23

129

723

(3042111) Morphology [Interpretation] in Bone marrow Narrative

115

702

1.65

6.08

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.09

6.03

1.3

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

2187

20030

1.15

6.01

5.2

4.6

0.0

estimate

0.50

484

3677

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

372

1.89

5.95

1.2

1.5

22.9

29.0

0.92

231

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4139

39699

1.17

5.94

7.2

6.0

42.9

40.2

mmol/mol

37.99

3895

36276

(3017446) Testosterone [Moles/volume] in Serum or Plasma

380

4870

0.76

5.93

2.4

2.1

11.8

12.8

nmol/l

1.50

329

4294

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

175

1192

1.48

5.76

4.7

1.5

8.2

3.9

mg/l

2.82

156

840

(3035350) Ketones [Presence] in Urine by Test strip

2178

20000

1.15

5.66

4.0

3.4

0.0

estimate

0.50

471

3595

(3009261) Glucose [Presence] in Urine by Test strip

2203

20279

1.14

5.47

4.0

3.5

0.0

estimate

1.49

447

3514

(3016650) Hepatitis A virus Ab [Presence] in Serum

579

1.67

5.37

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

175

1211

1.46

5.34

1.2

0.1

0.7

u/ml

1.68

113

(3028433) Virus identified in Specimen by Culture

143

2.39

5.29

1.2

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

137

2.42

5.28

1.1

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

507

1.71

5.24

1.7

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1338

0.59

5.22

1.5

1.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

258

1.99

5.06

2.6

302.2

570.0

e6/l

4.28

214

(3025159) Blasts/100 leukocytes in Blood

400

3180

1.28

5.04

4.7

4.1

0.1

0.3

1.10

138

777

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

110

2.55

5.03

1.9

1.5

9.1

9.4

ug/l

0.13

110

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.90

4.98

1.2

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

274

2073

1.34

4.97

1.4

1.3

183.2

302.9

u/ml

2.65

262

1894

(3010144) Erythrocytes [#/volume] in Synovial fluid

396

1.78

4.94

1.5

1.3

109378.4

112603.0

e6/l

0.02

274

(3029075) Extractable nuclear Ab panel - Serum

2.67

4.90

1.1

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

130

2.39

4.88

1.3

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

270

1.93

4.81

1.3

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

132

883

1.51

4.81

1.4

1.3

—

(3015736) pH of Urine

1698

15468

1.14

4.76

3.9

3.2

—

5.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

145

994

1.47

4.69

1.4

1.7

—

(3037556) Urate [Mass/volume] in Serum or Plasma

140

2.29

4.60

1.8

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

128

861

1.50

4.56

1.2

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

476

1.67

4.50

3.8

3.9

—

(40761511) CBC panel - Blood by Automated count

4484

43530

1.16

4.50

26.5

12.3

—

(3002619) Bacteria identified in Specimen by Culture

2.86

4.48

1.5

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

242

1.95

4.48

1.2

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

238

1.94

4.33

1.2

1.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

3.51

4.32

1.6

2.1

1.1

1.3

mmol/l

—

(3024263) Appearance of Synovial fluid

225

1.96

4.29

1.3

1.7

—

(21494434) Karyotype in Bone marrow

362

1.75

4.27

1.1

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

445

1.67

4.26

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

290

1.84

4.23

2.4

407.5

639.5

e6/l

1.48

112

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.84

4.22

2.1

1.7

—

(40768446) Kidney Pathology biopsy report

133

2.26

4.21

2.1

1.7

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

154

1094

1.42

4.17

1.4

1.5

0.5

8.1

iu/ml

0.83

239

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

250

1.89

4.10

2.7

0.2

0.3

e9/l

0.48

215

(40759836) Histone Ab [Presence] in Serum by Immunoblot

236

1.91

4.09

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

236

1.91

4.09

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

236

1.91

4.09

1.2

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

697

6011

1.18

4.03

1.2

48.5

40.7

iu/ml

0.40

194

1850

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

239

1.89

3.95

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

239

1.89

3.95

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

239

1.89

3.95

1.2

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

620

1.54

3.95

1.0

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

119

2.28

3.86

2.9

1.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

119

2.28

3.86

2.9

1.9

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

471

0.42

3.85

1.3

104.2

125.9

pmol/l

0.12

148

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

190

2513

0.75

3.81

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.53

3.76

1.0

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

147

2.12

3.73

3.5

2.1

—

(3047189) Immunofixation for 24 hour Urine

181

2.00

3.72

1.4

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

648

5593

1.18

3.71

16.2

6.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.01

3.69

1.1

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4133

40047

1.13

3.68

4.9

4.0

1.5

1.3

mmol/l

21.11

3869

36018

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

162

2.04

3.64

1.7

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

162

2.04

3.64

1.7

2.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

198

1.93

3.56

3.0

3.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

484

5702

0.83

3.56

5.0

4.6

31.7

31.8

0.10

375

3635

(3035320) C reactive protein [Mass/volume] in Body fluid

263

1.79

3.54

2.8

2.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

124

2.18

3.53

1.9

—

(3017704) Immunofixation for Urine

213

1.88

3.52

1.4

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2339

22016

1.11

3.48

2.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.42

3.46

1.1

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

127

905

1.41

3.45

2.1

1.6

1.3

0.8

nmol/l

4.37

111

760

(3000093) Morphology [Interpretation] in Blood Narrative

387

1.64

3.42

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.39

3.38

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

205

0.29

3.18

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

244

1.77

3.14

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

172

1.92

3.13

1.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

172

1.92

3.13

1.3

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

111

2.17

3.12

1.1

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.29

3.09

2.2

2.3

8.4

7.9

mmol/l

0.14

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

836

7463

1.14

3.06

1.2

1.3

2.1

2.0

u/ml

0.03

204

1916

(4094501)

1186

0.68

3.06

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

5.01

3.05

1.9

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.84

3.02

1.0

1.4

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.84

3.02

1.0

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

255

1.73

3.00

2.5

1.8

—

(3008037) Lactate [Moles/volume] in Venous blood

136

1008

1.36

2.97

4.6

2.7

1.6

mmol/l

0.03

130

984

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

241

1.75

2.97

1.1

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

234

1.76

2.95

2.3

2.1

80.6

189.3

ug/min

0.60

(3045142) Bone marrow Pathology biopsy report

507

1.51

2.95

1.3

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

162

1.92

2.94

1.8

2.1

—

(3044927) Protein electrophoresis panel - Urine

430

1.54

2.86

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

222

1.76

2.84

1.7

1.5

5.3

5.7

u/l

0.07

107

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.19

2.82

1.1

1.2

1.4

726.6

ug/l

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

261

1.69

2.79

1.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.47

2.78

1.0

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

383

0.47

2.76

3.6

3.0

13.3

13.2

0.20

378

(3049233) Organic acids panel - Urine

8.34

2.75

1.2

1.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.33

2.64

1.1

1.2

0.8

0.7

umol/24h

—

(3025549) Creatine [Moles/time] in 24 hour Urine

3.13

2.64

1.2

1.4

—

(3013336) Amino acids [Identifier] in Serum or Plasma

7.15

2.55

1.2

2.9

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.73

2.54

1.5

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

101

735

1.38

2.52

3.6

1.8

1.4

0.35

552

(3034891) Synovial lining cells/100 cells in Synovial fluid

188

1.76

2.44

1.1

1.5

3.5

4.1

0.12

(3019225) pH of Specimen

504

4417

1.16

2.43

6.1

3.8

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

226

1.69

2.42

1.3

1.8

1.5

3.2

u/field

1.01

154

(3014271) Vancomycin [Susceptibility]

212

1.70

2.38

2.8

2.7

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.35

2.38

1.8

3.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

466

1.46

2.38

3.2

3.5

62.9

56.9

1.30

284

(3020191) Ethanol [Moles/volume] in Serum or Plasma

361

1.53

2.37

1.4

1.3

1.1

1.4

promille

0.58

281

(3005011) Chlamydia sp Ab [Titer] in Serum

2.61

2.35

1.4

1.7

—

(3036603) Volume of Urine

252

1.63

2.32

1.5

1.6

1743.8

2037.2

0.64

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.09

2.32

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

126

963

1.32

2.32

4.8

2.7

7.5

7.6

mmol/l

0.30

121

944

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

253

1.63

2.29

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

253

1.63

2.29

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

155

1.81

2.29

1.6

1.8

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.69

2.27

1.7

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1057

11449

0.90

2.26

1.5

1.6

1.4

mmol/l

4.49

890

9549

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

473

1.44

2.23

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

155

1226

1.27

2.21

1.5

1.4

248.0

263.8

ug/g

0.45

103

719

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

245

2931

0.83

2.21

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

549

1.41

2.21

3.9

1.9

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

343

1.52

2.21

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

2.20

1.1

1.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

141

1103

1.29

2.20

1.5

1.7

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

389

0.54

2.18

1.0

253.3

314.2

ng/l

0.55

264

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.69

2.15

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.17

2.14

1.4

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

191

1.68

2.06

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.50

2.05

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

2.15

1.98

2.7

3.4

1.2

mmol/l

0.82

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

388

0.57

1.96

1.0

748.3

715.0

ng/l

0.14

257

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

388

0.57

1.96

1.0

35.1

43.1

ng/l

0.48

258

(3011985) Renin [Units/volume] in Plasma

503

1.40

1.96

1.3

1.4

69.4

57.5

mu/l

0.28

455

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

529

1.39

1.95

1.4

1.3

0.2

0.4

nmol/l

0.66

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

4.55

1.94

1.2

1.5

37.6

10.1

nmol/l

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

4.55

1.94

2.0

1.4

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

4.55

1.94

1.0

1.1

—

(3019174) dRVVT (LA screen)

2.97

1.93

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.97

1.93

1.0

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

290

1.52

1.91

1.2

10.2

11.7

mmol/l

1.39

104

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.31

1.87

1.2

1.7

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

724

1.32

1.85

1.1

1.2

—

19.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.39

1.85

1.5

2.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

182

1.65

1.84

1.5

2.3

5.0

14.5

umol/l

1.21

124

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

623

5654

1.11

1.79

1.2

12.5

14.8

u/ml

0.36

225

2082

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

239

1.55

1.78

1.5

1.3

11.1

6.2

u/l

0.39

194

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

147

1.70

1.73

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

160

1313

1.23

1.72

1.7

1.6

—

(3050794) Legionella sp Ab [Presence] in Serum

2.67

1.72

1.1

1.2

—

(3008898) HLA-B27 [Presence]

1027

0.76

1.69

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.58

1.65

1.9

2.6

—

(3034988) Calcium [Moles/volume] in Capillary blood

1.98

1.64

2.7

3.9

1.2

mmol/l

0.43

(3045414) Leukocytes [Presence] in Urine

216

1837

1.18

1.62

1.9

1.8

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.00

1.58

1.3

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

157

0.45

1.54

1.0

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

113

908

1.25

1.51

2.3

2.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

193

1.56

1.50

1.0

1.1

—

(4198724)

123

1.71

1.50

1.8

1.6

—

(1002224) Polysomnography panel

126

1539

0.81

1.50

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

182

0.49

1.50

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

182

0.49

1.50

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

182

0.49

1.50

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

182

0.49

1.50

1.2

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

985

9226

1.08

1.47

1.7

29733447.0

27246671.0

pmol/l

0.05

824

7557

(3045683) HLA typing for celiac disease panel - Blood or Tissue

168

0.48

1.46

1.1

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

106

1314

0.80

1.46

5.0

3.9

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

480

1.34

1.45

1.1

1.4

314.1

279.8

pmol/l

0.28

362

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.13

1.44

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

2.73

1.43

5.2

2.2

4.4

4.2

mmol/l

—

(3020393) Adenovirus Ag [Presence] in Stool

2.04

1.43

1.9

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.97

1.43

2.5

1.5

207.7

150.6

ng/l

0.32

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

457

1.34

1.40

1.4

1.3

—

nmol/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

366

4079

0.89

1.38

1.5

—

(40768795) Lymph node Pathology biopsy report

407

1.35

1.37

1.3

1.2

—

(3049717) Cytology report of Urine Cyto stain

243

2119

1.15

1.37

2.8

2.9

—

(3028707) Methadone [Presence] in Urine by Screen method

382

1.36

3.3

2.6

—

(3048879) Bone marrow aspiration report

127

1.66

1.36

2.0

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

374

1.37

1.35

1.3

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.13

1.33

1.0

1.4

—

mmol/l

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

200

1.50

1.32

2.0

2.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

113

1.68

1.31

1.0

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

148

0.47

1.31

1.1

1.4

—

(3005033) Fetal Nuchal fold Thickness US

148

0.47

1.31

1.1

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

149

0.47

1.31

1.1

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

1.81

1.31

1.5

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

194

0.51

1.30

1.3

1.5

—

(3044009) aPTT.lupus sensitive (LA screen)

2.50

1.30

1.3

—

(44806071)

2.09

1.30

1.0

1.1

—

(3022621) pH of Urine by Test strip

310

2761

1.13

1.29

2.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

355

0.65

1.29

1.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.78

1.28

4.0

2.3

—

(3046861) Legionella sp Ag [Presence] in Urine

2.78

1.28

1.2

1.0

—

(3016750) Collection duration of Urine

251

1.44

1.28

2.0

2.2

506.5

489.2

min

0.48

186

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

553

0.72

1.27

1.3

1.1

0.7

1.6

u/ml

1.31

239

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

371

1.35

1.25

1.1

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.22

1.24

1.0

1.3

1.8

1.7

umol/24h

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

469

0.70

1.23

1.1

1.2

1.3

u/ml

0.04

215

(40768443) Skin Pathology biopsy report

213

1857

1.15

1.23

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

1.77

1.22

1.7

1.8

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.04

1.22

1.6

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.04

1.22

1.6

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.04

1.22

1.6

1.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

432

0.69

1.21

1.0

1.1

—

19.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1184

0.82

1.20

1.7

1.9

204.1

205.3

pmol/l

0.05

1099

(3008295) Osmolality of Serum or Plasma

426

1.32

1.20

1.3

1.4

276.6

282.7

mosm/kgh2o

0.79

332

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

109

1.65

1.18

1.2

33.7

36.7

0.11

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4588

45337

1.07

1.17

37.7

15.3

99.4

81.1

umol/l

99.01

4582

45315

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.00

1.16

1.0

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

101

831

1.22

1.15

1.2

5.8

5.9

u/ml

0.01

125

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

482

1.29

1.15

1.3

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

482

1.29

1.15

1.3

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

586

0.75

1.12

1.5

1.4

—

(3004775) Volume in Urine collected for unspecified duration

370

1.33

1.12

2.2

741.2

642.2

0.72

241

(3020491) Glucose [Moles/volume] in Blood

301

1.36

1.12

2.1

1.8

8.5

6.7

mmol/l

1.41

194

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.33

1.12

13.3

9.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

484

1.28

1.12

1.3

1.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.90

1.12

1.1

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

436

0.71

1.12

1.2

1.1

2.5

2.9

u/ml

—

103

(40768441) Liver Pathology biopsy report

310

1.36

1.11

1.2

1.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.38

1.09

1.4

1.8

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.92

1.06

1.0

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.92

1.06

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1154

0.83

1.05

1.9

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

137

1.53

1.05

1.0

1.1

1593.5

1632.3

miu/ml

0.05

137

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.27

1.03

4.0

5.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

483

1.27

1.01

1.3

1.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

106

0.47

1.01

1.4

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

250

2241

1.12

1.00

2.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.62

0.99

1.2

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.71

0.98

1.2

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

102

857

1.19

0.98

1.3

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

240

1.38

0.98

2.1

2.7

44.4

35.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.17

0.98

1.8

1.7

—

(4024509)

378

0.71

0.97

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

822

1.20

0.96

1.2

4.2

3.6

u/ml

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

496

1.25

0.95

1.3

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

407

1.28

0.95

1.6

2.2

1039.7

2326.1

u/l

0.63

135

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

294

0.68

0.95

1.1

1.0

0.9

0.4

u/ml

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

311

1.32

0.94

1.4

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

3820

37627

1.05

0.94

34.6

14.2

39.5

40.0

2.21

2567

25664

(3020650) Glucose [Presence] in Urine

120

0.50

0.93

1.2

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

362

0.72

0.92

1.2

1.0

4.3

2.9

u/ml

—

145

(3028679) Herpes simplex virus Ab [Presence] in Serum

167

1.44

0.91

1.2

1.1

—

(3017509) Phencyclidine [Presence] in Urine

2.14

0.91

1.7

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

338

0.71

0.91

1.1

1.0

10.0

4.3

u/ml

—

135

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

266

0.68

0.89

1.0

1.1

—

(44806420)

135

1.48

0.89

2.2

2.4

—

(4133840)

105

0.48

0.88

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

484

1.24

0.88

1.3

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.61

0.87

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

4656

46968

0.94

0.85

42.9

19.3

133.7

137.8

g/l

50.04

4589

46102

(3010813) Leukocytes [#/volume] in Blood

4656

46967

0.94

0.85

42.6

19.2

7.3

6.8

e9/l

16.28

4546

45297

(3003338) MCHC [Mass/volume]

3558

35029

1.04

0.84

40.6

16.9

329.9

333.6

g/l

96.68

3514

34738

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.63

0.84

1.5

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

129

1.47

0.83

1.4

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

115

0.52

0.82

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

115

0.52

0.82

1.0

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

4656

46956

0.94

0.81

42.5

19.2

4.4

4.5

e12/l

40.85

4549

45287

(3024731) MCV [Entitic volume]

4656

46954

0.94

0.81

42.4

19.2

92.4

91.3

47.48

4588

46102

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

176

0.62

0.79

1.1

—

(3035941) MCH [Entitic mass]

4656

46949

0.95

0.79

42.3

19.1

30.5

0.38

4586

46098

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

208

1878

1.11

0.78

1.2

115.5

131.8

iu/ml

0.22

653

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

124

0.56

0.77

1.0

1.1

—

(3007461) Platelets [#/volume] in Blood

4655

46931

0.95

0.77

42.6

19.2

225.5

242.8

e9/l

58.31

4558

45432

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

126

0.55

0.77

1.0

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4196

41502

1.05

0.76

5.2

4.5

1.3

1.4

mmol/l

121.11

3943

37625

(40768793) Breast Pathology biopsy report

559

0.80

0.74

1.2

1.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.08

0.74

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.67

0.74

1.4

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

480

0.79

0.73

1.1

7.5

5.1

u/ml

0.32

245

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

300

0.73

4.0

5.3

32.1

46.1

u/ml

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

227

2487

0.91

0.72

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

692

1.17

0.70

1.1

171.4

297.4

iu/ml

—

152

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

203

1.33

0.70

1.6

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.85

0.68

1.4

1.3

291.8

336.3

umol/24h

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.85

0.68

1.4

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.85

0.68

7.6

3.3

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

1.64

0.68

1.1

5.3

8.6

mg/g

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4229

41878

1.04

0.66

5.3

4.5

4.1

4.6

mmol/l

134.69

3994

38237

(3026389) Candida sp identified in Specimen by Organism specific culture

457

1.21

0.66

1.5

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

111

1.44

0.65

1.8

1.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.59

0.65

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.59

0.65

1.1

1.6

50.3

44.4

umol/l

—

(36660697) Celiac disease serology panel - Serum

291

2701

1.08

0.64

1.1

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

293

0.75

0.64

1.2

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

493

0.81

0.64

1.2

8.0

7.6

mmol/l

0.36

345

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

153

0.65

0.62

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

101

0.59

0.62

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

211

0.71

0.62

1.5

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

164

0.67

0.61

1.0

1.2

—

(3003694) ABO and Rh group [Type] in Blood

1156

11194

1.04

0.60

1.4

1.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.48

0.60

1.2

1598.6

261.0

pmol/l

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.60

0.0

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

183

1.31

0.59

1.0

1.1

71.9

95.5

u/l

1.34

142

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.58

0.0

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.46

0.58

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.72

0.57

1.7

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

184

1.31

0.57

1.0

1.1

13.4

34.7

u/l

2.31

136

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.67

0.56

1.2

1.0

5.5

7.0

u/l

—

(3020961) Endomysium IgA Ab [Titer] in Serum

170

1557

1.09

0.54

1.1

44.3

277.4

titre

—

(4212803)

1.58

0.54

1.2

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.46

0.54

1.1

1.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

899

0.88

0.54

1.6

490.3

843.1

e6/l

0.56

730

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

898

0.88

0.53

1.5

93.5

18.4

e6/l

0.48

689

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.50

0.51

1.0

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.41

0.51

2.3

2.5

76.2

72.9

pmol/l

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

224

2406

0.93

0.51

1.2

1.3

41.5

58.0

au/ml

—

101

(3036071) Salmonella sp Ab [Titer] in Serum

109

1.38

0.50

1.0

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

144

1.32

0.50

2.8

3.8

56.0

55.0

0.07

138

(40765096) Chromosome analysis panel by Banding

144

1.32

0.50

1.1

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

188

1738

1.08

0.50

2.6

3.8

356.9

1746.4

u/ml

1.18

155

1512

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

478

5007

0.95

0.49

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

234

1.24

0.49

1.4

1.3

1.7

1.2

nmol/l

1.05

171

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

216

1.25

0.49

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4556

45265

1.04

0.49

16.4

10.0

29.2

27.4

u/l

3.21

4422

43345

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

212

0.75

0.48

5.5

6.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

107

965

1.11

0.48

1.2

1.3

—

(3022145) Colonoscopy Study observation

502

4803

1.05

0.47

1.3

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

137

1.31

0.47

1.0

1.1

7.5

4.6

u/ml

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.46

0.46

4.0

5.5

53.4

46.5

ug/min

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

200

1.25

0.46

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.43

0.46

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

117

0.68

0.45

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

121

0.66

0.45

1.0

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.45

0.44

1.1

—

(3025130) Human papilloma virus identified in Specimen

211

1.23

0.43

1.7

1.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

659

1.12

0.43

2.6

2.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.43

0.42

1.0

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

122

1.31

0.42

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.56

0.42

1.0

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

167

1.26

0.41

1.4

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

921

0.90

0.41

1.3

1.4

3.8

mmol/l

0.05

870

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

(3003129) Base excess in Capillary blood by calculation

123

1.30

0.40

2.8

1.7

0.9

0.1

mmol/l

0.22

114

(3009214) Lutropin [Units/volume] in Serum or Plasma

108

987

1.10

0.40

1.6

1.4

9.8

7.8

u/l

0.79

796

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

856

0.90

0.40

1.2

1.1

12.4

7.8

u/ml

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.40

0.0

1.0

—

(3000285) Sodium [Moles/volume] in Blood

1.31

0.39

1.1

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.31

0.39

2.0

1.8

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.39

0.0

1.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.39

0.0

1.1

—

(4211845)

204

0.78

0.39

2.6

3.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1580

15510

1.03

0.38

4.4

3.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

113

0.71

0.37

2.4

—

(4034850)

146

1361

1.07

0.36

23.0

8.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

236

1.19

0.34

1.4

1.3

0.6

2.2

u/ml

1.08

110

(3036670) Protein [Mass/volume] in Synovial fluid

136

1.25

0.33

1.0

1.2

36.8

38.7

g/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

548

1.11

0.33

1.3

—

(4027681)

210

0.81

0.33

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

154

0.78

0.32

1.1

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

101

1.29

0.31

1.0

1.5

1.7

6.9

ug/l

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

324

1.14

0.30

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

838

0.92

0.29

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

184

0.81

0.28

1.1

1.0

1.1

u/l

—

(3000034) Microalbumin [Mass/volume] in Urine

440

1.11

0.28

3.5

3.0

13.6

48.3

mg/l

1.78

323

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

195

1.18

0.28

2.3

2.7

—

30.0

—

(40768804) Tissue Pathology biopsy report

1664

16861

0.98

0.26

2.1

2.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

357

1.12

0.26

1.6

2.0

1.5

1.9

u/field

0.19

132

(3000330) Specific gravity of Urine by Test strip

220

2298

0.96

0.26

4.0

3.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.30

0.26

1.0

1.7

2.6

2.3

ug/l

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4308

42886

1.02

0.25

5.8

5.0

2.4

2.7

mmol/l

96.59

4045

38972

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4168

41479

1.02

0.25

5.4

4.7

6.4

6.0

mmol/l

40.98

3825

37338

(3025577) Chromium [Mass/volume] in Blood

330

0.88

0.25

2.1

2.0

ug/l

0.07

268

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

508

0.90

0.25

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

207

1.16

0.25

1.1

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

398

1.11

0.24

1.5

—

(4146454)

557

0.91

0.23

2.6

2.8

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.28

0.23

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

348

0.89

0.22

1.3

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

209

1.15

0.22

1.1

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.25

0.22

1.4

1.5

—

(3019150) Specific gravity of Urine by Refractometry

900

8849

1.02

0.21

4.8

3.8

1.0

kg/l

2.57

128

1394

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

163

1.17

0.21

1.1

1.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.19

0.21

1.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.2

—

2.7

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

135

1.19

0.21

2.1

2.3

145.6

139.7

nmol/l

0.09

120

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

102

0.78

0.21

1.1

1.7

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

117

1.20

0.20

4.1

2.9

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.22

0.20

1.7

2.6

0.2

0.3

u/field

—

(3011288) Drugs identified in Urine by Screen method

548

1.08

0.20

8.3

2.8

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.20

0.19

3.5

2.8

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

174

1.15

0.19

3.1

2.3

67.3

53.2

umol/l

0.86

137

(3006462) Nitrate [Presence] in Urine

186

0.86

0.19

2.6

3.6

—

(3016879) Cocaine [Presence] in Urine

802

1.06

0.19

2.7

2.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.13

0.18

1.3

1.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

804

1.06

0.18

1.5

1.4

26.9

27.6

iu/l

0.06

666

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

214

1.12

0.17

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

138

1.16

0.17

1.5

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

161

1671

0.96

0.17

1.0

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

188

1.12

0.14

1.1

8.7

11.0

iu/ml

—

(3035933) Granulocytes/100 leukocytes in Blood

1.18

0.14

1.1

1.5

—

(3015183) Erythrocyte sedimentation rate

160

0.87

0.14

1.5

1.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

0.82

0.13

1.3

1.2

—

546.7

—

(3051101) Glucose [Moles/volume] in Cord blood

0.81

0.13

8.5

6.8

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

170

0.88

0.13

1.8

1.5

25.7

29.4

umol/l

1.34

162

(3024869) Neuronal Ab [Presence] in Serum

1.17

0.13

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

147

0.88

0.11

1.5

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

105

1.14

0.11

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

105

1.14

0.11

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

105

1.14

0.11

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

105

1.14

0.11

1.0

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

638

0.96

0.10

4.1

4.7

322.8

352.9

umol/l

0.90

536

(3002256) Pathology report gross observation

581

5741

1.01

0.10

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

203

1986

1.02

0.10

1.7

1.8

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

545

1.05

0.10

3.4

3.5

11.8

16.2

nmol/l

0.16

536

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

585

0.96

0.09

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

203

1.08

0.09

1.2

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

100

971

1.03

0.09

5.3

3.2

25.3

29.1

mg/l

0.60

608

(40762814) Titanium [Mass/volume] in Blood

1.13

0.09

2.5

2.1

3.0

4.2

ug/l

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

216

0.93

0.08

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.82

0.08

1.0

1.6

—

(40758292) HTLV I+II Ab panel - Serum

0.77

0.08

1.4

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

391

1.05

0.08

1.0

1.1

—

2.5

—

(3004616) Nuclear Ab [Presence] in Serum

451

1.04

0.07

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.04

0.07

1.4

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

112

0.89

0.07

1.2

1.3

2.8

3.8

umol/l

—

105

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

428

0.96

0.07

1.1

2.4

2.8

u/ml

0.20

182

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.86

0.06

1.3

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.84

0.06

1.4

2.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

224

0.94

0.06

10.2

14.0

982.7

803.6

nmol/l

0.84

209

(3023410) Appearance of Cerebral spinal fluid

396

0.96

0.06

1.9

1.8

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

111

0.90

0.06

3.2

3.6

7.7

7.6

mg/l

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

109

1.10

0.06

1.5

1.2

122.9

108.2

1.56

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

276

1.05

0.06

1.1

1.5

1.0

g/l

0.07

276

(3016018) Differential panel - Cerebral spinal fluid

444

1.04

0.06

1.5

—

(3027008) Opiates [Presence] in Urine

860

1.02

0.06

2.6

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

851

1.02

0.05

2.7

2.0

—

(3028300) Cannabinoids [Presence] in Urine

861

1.02

0.05

2.6

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

216

2186

0.99

0.05

1.8

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

293

0.96

0.05

1.5

1.3

18.0

25.1

u/l

0.80

242

(3025018) Bordetella pertussis Ab [Titer] in Serum

171

0.94

0.05

1.3

1.2

—

(3027944) Amphetamines [Presence] in Urine

843

1.02

0.04

2.7

2.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

466

1.03

0.04

1.2

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

109

0.92

0.04

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

664

0.98

0.04

1.5

2.1

—

(4015189)

111

1.08

0.04

1.6

2.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

468

1.03

0.03

1.2

1.1

—

(3017732) Neutrophils [#/volume] in Blood

284

2859

0.99

0.03

2.8

3.1

4.6

4.1

e9/l

2.59

211

2133

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

221

1.04

0.03

1.7

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

418

4199

1.00

0.02

2.0

2.4

143.9

155.8

ug/g

0.27

326

3301

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

570

1.02

0.02

1.8

24.9

27.8

mg/l

0.13

139

(3045424) Erythrocytes [Presence] in Urine

731

1.01

0.01

1.4

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

819

0.99

0.01

1.7

2.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

223

1.03

0.01

1.1

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

114

1.05

0.00

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

488

4874

1.00

0.00

3.2

4.6

9.7

23.6

ug/l

2.95

400

4112

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1.02

0.00

2.7

3.0

—

138.3

—

(3000012) Reticulocyte production index

235

1.02

0.00

1.4

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

107

1.03

0.00

1.3

1.5

—

(44813793)

224

0.98

0.00

1.1

—

(3006270) Folate [Moles/volume] in Blood

354

0.99

0.00

1.2

376.8

348.7

nmol/l

0.29

281

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

100

996

1.00

0.00

2.2

3.6

1113.8

894.7

u/ml

0.13

913

(3041096) Erythrocytes [Presence] in Urine by Automated

1072

10716

1.00

0.00

3.8

3.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1542.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.0

—

1.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.91

0.00

1.0

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.0

1.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.93

0.00

1.4

2.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

0.90

0.00

2.7

1.8

46.0

61.2

pmol/l

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.9

—

0.3

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

2.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.93

0.00

1.0

2.3

15.5

18.1

umol/l

—

Mortality – FinRegistry

↥

Association

Association between endpoint FG_CARDMYO and mortality.

Females

Parameter	HR [95% CI]	p-value
FG_CARDMYO	2.852 [2.59, 3.15]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.042

During the follow-up period (1.1.1998 — 31.12.2019), 3005 out of 8180 females with FG_CARDMYO died.

Males

Parameter	HR [95% CI]	p-value
FG_CARDMYO	3.025 [2.76, 3.32]	< 0.001
Birth year	0.984 [0.97, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 9127 out of 21265 males with FG_CARDMYO died.

Mortality risk

Mortality risk for people of age

years, who have FG_CARDMYO.

N-year risk	Females	Males
1	0.255%	0.477%
5	1.473%	2.783%
10	3.625%	6.932%
15	6.938%	13.45%
20	11.72%	21.585%

Relationships between endpoints

↥

Index endpoint: FG_CARDMYO – Cardiomyopathy (excluding other)

GWS hits: 25

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cardiomyopathy (excluding other)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints